Gene,rsId,Ref,Alt,Effect,Alleles Frequency,Number of citation,Publications,Clinical Significant,ClinVar Accession,Cytogenetic location,Variant name,Disease name,Synonyms
HOXB13,rs138213197,C,T,"missense_variant,coding_sequence_variant","T=0.000994 (263/264690, TOPMED).T=0.001843 (460/249538, GnomAD_exome).T=0.001605 (225/140226, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs138213197,Pathogenic,RCV000210093.2,17q21.32,NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu),Prostate cancer susceptibility,MedGen: C3469524
HOXB13,rs138213197,C,T,"missense_variant,coding_sequence_variant","T=0.000994 (263/264690, TOPMED).T=0.001843 (460/249538, GnomAD_exome).T=0.001605 (225/140226, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs138213197,Pathogenic-Likely-Pathogenic,RCV000714291.6,17q21.32,NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu),"Prostate cancer, hereditary, 9 (HPC9)
                    ",MONDO: MONDO:0012597; MedGen: C1970250; Orphanet: 1331; OMIM: 610997
HOXB13,rs138213197,C,T,"missense_variant,coding_sequence_variant","T=0.000994 (263/264690, TOPMED).T=0.001843 (460/249538, GnomAD_exome).T=0.001605 (225/140226, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs138213197,Likely-Pathogenic,RCV001391199.1,17q21.32,NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu),Carcinoma of pancreas,"PANCREATIC ACINAR CARCINOMA; PANCREATIC CARCINOMA; Pancreatic cancer, somatic; See all synonyms [MedGen]"
HOXB13,rs138213197,C,T,"missense_variant,coding_sequence_variant","T=0.000994 (263/264690, TOPMED).T=0.001843 (460/249538, GnomAD_exome).T=0.001605 (225/140226, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs138213197,Pathogenic,RCV001582580.1,17q21.32,NM_006361.6(HOXB13):c.251G>A (p.Gly84Glu),Familial prostate carcinoma,Familial prostate cancer; Hereditary prostate cancer
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000420757.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000422470.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000423098.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000424391.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000427302.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000431015.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000432499.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000432733.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000435578.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000437532.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000442518.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000444550.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs28933406,G,C,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000444619.1,11p15.5,NM_005343.4(HRAS):c.181C>G (p.Gln61Glu),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs28933406,G,T,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Pathogenic,RCV000013434.9,11p15.5,NM_005343.4(HRAS):c.181C>A (p.Gln61Lys),"Thyroid cancer, nonmedullary, 2 (NMTC2)
                    ","Thyroid carcinoma, follicular, somatic; THYROID CANCER, NONMEDULLARY, 2, SUSCEPTIBILITY TO"
HRAS,rs28933406,G,T,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Pathogenic,RCV000022795.9,11p15.5,NM_005343.4(HRAS):c.181C>A (p.Gln61Lys),Spermatocytic seminoma,"Spermatocytic seminoma, somatic"
HRAS,rs28933406,G,T,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000439343.1,11p15.5,NM_005343.4(HRAS):c.181C>A (p.Gln61Lys),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs28933406,G,T,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Likely-Pathogenic,RCV000587258.1,11p15.5,NM_005343.4(HRAS):c.181C>A (p.Gln61Lys),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
HRAS,rs28933406,G,T,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Pathogenic,RCV000681435.1,11p15.5,NM_005343.4(HRAS):c.181C>A (p.Gln61Lys),none provided,MedGen: CN517202
HRAS,rs28933406,G,T,"coding_sequence_variant,missense_variant,5_prime_UTR_variant,intron_variant,stop_gained,genic_upstream_transcript_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs28933406#publications,Pathogenic,RCV001255683.1,11p15.5,NM_005343.4(HRAS):c.181C>A (p.Gln61Lys),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV000157914.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),none provided,MedGen: CN517202
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000418565.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000418712.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000419846.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000421468.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000424767.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000426169.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000427265.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000428389.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000429433.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000432148.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000434580.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000436822.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000437080.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000439230.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000442670.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000444507.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000444587.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic-Likely-Pathogenic,RCV000590121.3,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV001255688.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
HRAS,rs104894226,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV001849323.1,11p15.5,NM_005343.4(HRAS):c.38G>T (p.Gly13Val),KA-like vemurafenib-induced squamous lesions,
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000421384.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000424186.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000425652.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000426316.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000433957.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000434248.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000434457.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000440965.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000442365.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894226,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Likely-Pathogenic,RCV000445345.1,11p15.5,NM_005343.4(HRAS):c.38G>C (p.Gly13Ala),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs104894226,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV000013438.31,11p15.5,NM_005343.4(HRAS):c.38G>A (p.Gly13Asp),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894226,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV000157913.10,11p15.5,NM_005343.4(HRAS):c.38G>A (p.Gly13Asp),none provided,MedGen: CN517202
HRAS,rs104894226,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV000781469.1,11p15.5,NM_005343.4(HRAS):c.38G>A (p.Gly13Asp),RASopathy,rasopathies; Noonan spectrum disorder
HRAS,rs104894226,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV001376018.1,11p15.5,NM_005343.4(HRAS):c.38G>A (p.Gly13Asp),"Non-immune hydrops fetalis (NIHF)
                    ",Idiopathic hydrops fetalis; Familial non-immune hydrops fetalis; Fetal edema
HRAS,rs104894226,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","T=0.000 (0/476, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs104894226,Pathogenic,RCV001813187.1,11p15.5,NM_005343.4(HRAS):c.38G>A (p.Gly13Asp),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs104894227,T,C,"coding_sequence_variant,genic_upstream_transcript_variant,intron_variant,missense_variant","C=0.000 (0/478, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894227,Pathogenic,RCV000013439.28,11p15.5,NM_005343.4(HRAS):c.350A>G (p.Lys117Arg),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894227,T,C,"coding_sequence_variant,genic_upstream_transcript_variant,intron_variant,missense_variant","C=0.000 (0/478, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs104894227,Pathogenic,RCV000353386.2,11p15.5,NM_005343.4(HRAS):c.350A>G (p.Lys117Arg),none provided,MedGen: CN517202
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000013440.36,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000149831.3,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),RASopathy,rasopathies; Noonan spectrum disorder
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000207504.7,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),none provided,MedGen: CN517202
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000417661.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000420958.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000423190.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000424247.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000425964.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000426653.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000428812.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000431688.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000433893.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000434069.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000436007.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000436205.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000439052.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000439954.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Neoplasm,Neoplasms; Neoplasm (disease)
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000441514.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000444110.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000445225.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000445336.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000678903.2,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000762847.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),"Large congenital melanocytic nevus (CMNS)
                    ",Giant pigmented hairy nevus; Giant hairy nevus; Bathing trunk nevus; See all synonyms [MedGen]
HRAS,rs104894228,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV001813188.1,11p15.5,NM_005343.4(HRAS):c.37G>T (p.Gly13Cys),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000029212.9,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Nevus sebaceous,"NEVUS SEBACEOUS, SOMATIC"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000029213.9,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Linear nevus sebaceous syndrome,SFM syndrome; Jadassohn nevus phakomatosis; Nevus sebaceus of Jadassohn; See all synonyms [MedGen]
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000032852.9,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Epidermal nevus,"NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC; Nevus, epidermal, somatic"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000173005.5,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"NEVUS SPILUS, SOMATIC",
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000173006.5,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"SPITZ NEVUS, SOMATIC",
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV000418725.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000419344.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000420422.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000420481.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000422625.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000424371.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000427669.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000430065.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000430227.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000431824.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000432361.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000435072.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000437649.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000439525.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000439826.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000440902.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000443949.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV001255682.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV001376004.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"Non-immune hydrops fetalis (NIHF)
                    ",Idiopathic hydrops fetalis; Familial non-immune hydrops fetalis; Fetal edema
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV001781319.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Pathogenic,RCV001813211.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs104894228,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV001849283.1,11p15.5,NM_005343.4(HRAS):c.37G>C (p.Gly13Arg),cutaneous-skeletal hypophosphatemia syndrome,
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000417857.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000422141.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),Neoplasm,Neoplasms; Neoplasm (disease)
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000424171.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000427918.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000430043.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000430707.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000435549.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000440979.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs104894228,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant","A=0.000 (0/476, ALFA)",22,https://www.ncbi.nlm.nih.gov/snp/rs104894228,Likely-Pathogenic,RCV000662270.1,11p15.5,NM_005343.4(HRAS):c.37G>A (p.Gly13Ser),Vascular Tumors Including Pyogenic Granuloma,
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000013447.33,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000029211.9,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Nevus sebaceous,"NEVUS SEBACEOUS, SOMATIC"
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000032851.9,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Epidermal nevus,"NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC; Nevus, epidermal, somatic"
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000149829.3,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),RASopathy,rasopathies; Noonan spectrum disorder
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000212495.11,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),none provided,MedGen: CN517202
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000418395.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000419553.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Myelodysplastic syndrome (MDS)
                    ","MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO; Myelodysplastic syndrome, somatic; Myelodysplastic syndromes"
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000421701.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000422023.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000424087.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000424380.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000426992.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000427213.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Papillary renal cell carcinoma, sporadic",MeSH: C538614; MedGen: C1336078
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000428012.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000429096.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000429404.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000431602.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Ovarian serous cystadenocarcinoma,MONDO: MONDO:0006046; MedGen: C0279663
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000431815.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Nasopharyngeal neoplasm,Nasopharyngeal Neoplasms; Neoplasia of the nasopharynx
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000434677.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Glioblastoma,Giant cell glioblastoma (histologic variant); Gliosarcoma (histologic variant)
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000436505.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000436802.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Carcinoma of esophagus,Oesophageal carcinoma; Esophageal carcinoma
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000437868.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Uterine carcinosarcoma,MONDO: MONDO:0006485; MedGen: C0280630
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000438707.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000438902.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000439243.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000440052.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Urinary bladder carcinoma,Bladder carcinoma
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000443678.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Prostate adenocarcinoma,Adenocarcinoma of prostate
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000443826.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Adenoid cystic carcinoma,Adenocystic carcinoma
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000444512.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000445233.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs104894229,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000762849.1,11p15.5,NM_005343.4(HRAS):c.34G>T (p.Gly12Cys),"Large congenital melanocytic nevus (CMNS)
                    ",Giant pigmented hairy nevus; Giant hairy nevus; Bathing trunk nevus; See all synonyms [MedGen]
HRAS,rs104894229,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000421560.1,11p15.5,NM_005343.4(HRAS):c.34G>C (p.Gly12Arg),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs104894229,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000431895.1,11p15.5,NM_005343.4(HRAS):c.34G>C (p.Gly12Arg),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894229,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV002230756.1,11p15.5,NM_005343.4(HRAS):c.34G>C (p.Gly12Arg),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000013435.52,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000013436.27,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Myopathy, congenital, with excess of muscle spindles",MONDO: MONDO:0800299; MedGen: C1968782
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000022796.8,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Epidermal nevus with urothelial cancer, somatic",MedGen: C3277679
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000029209.9,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Nevus sebaceous,"NEVUS SEBACEOUS, SOMATIC"
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000081295.17,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),none provided,MedGen: CN517202
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000149828.3,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),RASopathy,rasopathies; Noonan spectrum disorder
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000417494.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Uterine carcinosarcoma,MONDO: MONDO:0006485; MedGen: C0280630
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000419709.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000420366.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000422253.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Nasopharyngeal neoplasm,Nasopharyngeal Neoplasms; Neoplasia of the nasopharynx
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000422656.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000423310.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000424896.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000425542.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000427772.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Prostate adenocarcinoma,Adenocarcinoma of prostate
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000430011.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Ovarian serous cystadenocarcinoma,MONDO: MONDO:0006046; MedGen: C0279663
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000430608.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000430725.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000432342.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Papillary renal cell carcinoma, sporadic",MeSH: C538614; MedGen: C1336078
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000432945.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000432984.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Glioblastoma,Giant cell glioblastoma (histologic variant); Gliosarcoma (histologic variant)
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000433576.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000435163.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000438022.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000440237.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000440297.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000440863.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),"Myelodysplastic syndrome (MDS)
                    ","MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO; Myelodysplastic syndrome, somatic; Myelodysplastic syndromes"
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000440993.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Adenoid cystic carcinoma,Adenocystic carcinoma
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000443940.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Likely-Pathogenic,RCV000445039.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Carcinoma of esophagus,Oesophageal carcinoma; Esophageal carcinoma
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV000487471.3,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Woolly hair nevus,"NEVUS, WOOLLY HAIR, SOMATIC"
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV001255689.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV001257537.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Rhabdomyosarcoma,Rhabdomyosarcoma (disease)
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV001267097.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
HRAS,rs104894229,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,34,https://www.ncbi.nlm.nih.gov/snp/rs104894229,Pathogenic,RCV001813185.2,11p15.5,NM_005343.4(HRAS):c.34G>A (p.Gly12Ser),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs104894230,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000013431.7,11p15.5,NM_005343.4(HRAS):c.35G>T (p.Gly12Val),Malignant tumor of urinary bladder,Urinary bladder cancer; Urinary Bladder Neoplasms; Bladder cancer
HRAS,rs104894230,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000013432.31,11p15.5,NM_005343.4(HRAS):c.35G>T (p.Gly12Val),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894230,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000013433.27,11p15.5,NM_005343.4(HRAS):c.35G>T (p.Gly12Val),"Myopathy, congenital, with excess of muscle spindles",MONDO: MONDO:0800299; MedGen: C1968782
HRAS,rs104894230,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000032850.7,11p15.5,NM_005343.4(HRAS):c.35G>T (p.Gly12Val),Epidermal nevus,"NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC; Nevus, epidermal, somatic"
HRAS,rs104894230,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000157912.1,11p15.5,NM_005343.4(HRAS):c.35G>T (p.Gly12Val),none provided,MedGen: C3661900
HRAS,rs104894230,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000428111.1,11p15.5,NM_005343.4(HRAS):c.35G>T (p.Gly12Val),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
HRAS,rs104894230,C,A,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000438340.1,11p15.5,NM_005343.4(HRAS):c.35G>T (p.Gly12Val),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000013437.26,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000207503.4,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),none provided,MedGen: CN517202
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000417508.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000418547.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Adenoid cystic carcinoma,Adenocystic carcinoma
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000422263.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000423413.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000423622.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Ovarian serous cystadenocarcinoma,MONDO: MONDO:0006046; MedGen: C0279663
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000423741.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Carcinoma of esophagus,Oesophageal carcinoma; Esophageal carcinoma
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000425511.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Uterine carcinosarcoma,MONDO: MONDO:0006485; MedGen: C0280630
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000425989.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000426130.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000428172.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000428375.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Nasopharyngeal neoplasm,Nasopharyngeal Neoplasms; Neoplasia of the nasopharynx
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000430806.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Papillary renal cell carcinoma, sporadic",MeSH: C538614; MedGen: C1336078
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000432956.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000433266.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000433587.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Prostate adenocarcinoma,Adenocarcinoma of prostate
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000435619.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000435805.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000436832.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000440663.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Glioblastoma,Giant cell glioblastoma (histologic variant); Gliosarcoma (histologic variant)
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000441501.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000442448.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Myelodysplastic syndrome (MDS)
                    ","MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO; Myelodysplastic syndrome, somatic; Myelodysplastic syndromes"
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000444092.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000445090.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000445257.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000623953.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000762848.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),"Large congenital melanocytic nevus (CMNS)
                    ",Giant pigmented hairy nevus; Giant hairy nevus; Bathing trunk nevus; See all synonyms [MedGen]
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV001257536.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Rhabdomyosarcoma,Rhabdomyosarcoma (disease)
HRAS,rs104894230,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV001813186.1,11p15.5,NM_005343.4(HRAS):c.35G>C (p.Gly12Ala),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000013446.28,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),"Costello syndrome, severe",MedGen: C4016398
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000029210.10,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),Nevus sebaceous,"NEVUS SEBACEOUS, SOMATIC"
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000038460.6,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000149830.4,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),RASopathy,rasopathies; Noonan spectrum disorder
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV000212496.9,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),none provided,MedGen: CN517202
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV000429375.1,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV001255681.1,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Pathogenic,RCV001375956.1,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),"Non-immune hydrops fetalis (NIHF)
                    ",Idiopathic hydrops fetalis; Familial non-immune hydrops fetalis; Fetal edema
HRAS,rs104894230,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,missense_variant,5_prime_UTR_variant",None,25,https://www.ncbi.nlm.nih.gov/snp/rs104894230,Likely-Pathogenic,RCV001813189.1,11p15.5,NM_005343.4(HRAS):c.35G>A (p.Gly12Asp),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs104894231,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000417704.1,11p15.5,NM_005343.4(HRAS):c.436G>C (p.Ala146Pro),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894231,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000418346.1,11p15.5,NM_005343.4(HRAS):c.436G>C (p.Ala146Pro),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894231,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000427905.1,11p15.5,NM_005343.4(HRAS):c.436G>C (p.Ala146Pro),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894231,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000429488.1,11p15.5,NM_005343.4(HRAS):c.436G>C (p.Ala146Pro),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894231,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000439018.1,11p15.5,NM_005343.4(HRAS):c.436G>C (p.Ala146Pro),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs104894231,C,G,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000439704.1,11p15.5,NM_005343.4(HRAS):c.436G>C (p.Ala146Pro),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894231,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Pathogenic,RCV000013441.17,11p15.5,NM_005343.4(HRAS):c.436G>A (p.Ala146Thr),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs104894231,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000420974.1,11p15.5,NM_005343.4(HRAS):c.436G>A (p.Ala146Thr),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs104894231,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000427320.1,11p15.5,NM_005343.4(HRAS):c.436G>A (p.Ala146Thr),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs104894231,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000432069.1,11p15.5,NM_005343.4(HRAS):c.436G>A (p.Ala146Thr),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs104894231,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000434059.1,11p15.5,NM_005343.4(HRAS):c.436G>A (p.Ala146Thr),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs104894231,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000438623.1,11p15.5,NM_005343.4(HRAS):c.436G>A (p.Ala146Thr),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs104894231,C,T,"intron_variant,genic_upstream_transcript_variant,coding_sequence_variant,synonymous_variant,missense_variant","T=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894231,Likely-Pathogenic,RCV000444836.1,11p15.5,NM_005343.4(HRAS):c.436G>A (p.Ala146Thr),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000420395.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000420623.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000421690.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000421974.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000425694.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000426826.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000428206.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000428443.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000430634.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000433098.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000436845.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000437079.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000438263.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000438465.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Prostate adenocarcinoma,Adenocarcinoma of prostate
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000439626.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000445166.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000445204.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Pathogenic,RCV001255684.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
HRAS,rs121913233,T,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Pathogenic,RCV001849368.1,11p15.5,NM_005343.4(HRAS):c.182A>T (p.Gln61Leu),KA-like vemurafenib-induced squamous lesions,
HRAS,rs121913233,T,C,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Pathogenic,RCV000148033.4,11p15.5,NM_005343.4(HRAS):c.182A>G (p.Gln61Arg),Linear nevus sebaceous syndrome,SFM syndrome; Jadassohn nevus phakomatosis; Nevus sebaceus of Jadassohn; See all synonyms [MedGen]
HRAS,rs121913233,T,C,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000157918.2,11p15.5,NM_005343.4(HRAS):c.182A>G (p.Gln61Arg),none provided,MedGen: C3661900
HRAS,rs121913233,T,C,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Pathogenic,RCV000418550.1,11p15.5,NM_005343.4(HRAS):c.182A>G (p.Gln61Arg),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs121913233,T,C,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000437086.1,11p15.5,NM_005343.4(HRAS):c.182A>G (p.Gln61Arg),Neoplasm,Neoplasms; Neoplasm (disease)
HRAS,rs121913233,T,C,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000662268.1,11p15.5,NM_005343.4(HRAS):c.182A>G (p.Gln61Arg),Vascular Tumors Including Pyogenic Granuloma,
HRAS,rs121913233,T,C,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV001813393.1,11p15.5,NM_005343.4(HRAS):c.182A>G (p.Gln61Arg),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs121913233,T,C,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Pathogenic,RCV001844808.1,11p15.5,NM_005343.4(HRAS):c.182A>G (p.Gln61Arg),Salivary gland neoplasm,Tumor of salivary gland
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000417619.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000419094.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000420448.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000424105.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000425877.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000428681.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Neoplasm,Neoplasms; Neoplasm (disease)
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000428741.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000430030.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Malignant neoplasm of body of uterus,MedGen: C0153574
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000430658.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000435275.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000435489.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000435915.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000440764.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
HRAS,rs121913233,T,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs121913233,Likely-Pathogenic,RCV000441832.1,11p15.5,NM_005343.4(HRAS):c.182A>C (p.Gln61Pro),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000420806.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Neoplasm,Neoplasms; Neoplasm (disease)
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000421964.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000423449.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Breast neoplasm,Neoplasm of breast; Breast tumor; Neoplasm of the breast; See all synonyms [MedGen]
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000424686.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000433099.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000433734.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Prostate adenocarcinoma,Adenocarcinoma of prostate
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000434965.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Thyroid tumor,Neoplasm of the thyroid gland
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000440259.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000442468.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000444731.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),Squamous cell carcinoma of the skin,MONDO: MONDO:0002529; MedGen: C0553723; Human Phenotype Ontology: HP:0006739
HRAS,rs121913496,C,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000589258.1,11p15.5,NM_005343.4(HRAS):c.183G>T (p.Gln61His),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
HRAS,rs121913496,C,G,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,synonymous_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140244, GnomAD).T=0.00000 (0/14050, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913496,Likely-Pathogenic,RCV000428014.1,11p15.5,NM_005343.4(HRAS):c.183G>C (p.Gln61His),Neoplasm,Neoplasms; Neoplasm (disease)
HRAS,rs121917756,C,T,"stop_gained,5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121917756,Pathogenic,RCV000013442.23,11p15.5,NM_005343.4(HRAS):c.187G>A (p.Glu63Lys),"Myopathy, congenital, with excess of muscle spindles",MONDO: MONDO:0800299; MedGen: C1968782
HRAS,rs121917756,C,T,"stop_gained,5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121917756,Pathogenic,RCV000485616.1,11p15.5,NM_005343.4(HRAS):c.187G>A (p.Glu63Lys),none provided,MedGen: C3661900
HRAS,rs121917756,C,T,"stop_gained,5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121917756,Pathogenic,RCV002272015.1,11p15.5,NM_005343.4(HRAS):c.187G>A (p.Glu63Lys),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs121917757,G,T,"stop_gained,5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant","A=0.000012 (3/250698, GnomAD_exome).A=0.000025 (3/120338, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs121917757,Pathogenic,RCV000013443.17,11p15.5,NM_005343.4(HRAS):c.64C>A (p.Gln22Lys),"Myopathy, congenital, with excess of muscle spindles",MONDO: MONDO:0800299; MedGen: C1968782
HRAS,rs121917757,G,T,"stop_gained,5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant","A=0.000012 (3/250698, GnomAD_exome).A=0.000025 (3/120338, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs121917757,Likely-Pathogenic,RCV000143898.4,11p15.5,NM_005343.4(HRAS):c.64C>A (p.Gln22Lys),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs121917757,G,T,"stop_gained,5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant","A=0.000012 (3/250698, GnomAD_exome).A=0.000025 (3/120338, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs121917757,Likely-Pathogenic,RCV000157915.1,11p15.5,NM_005343.4(HRAS):c.64C>A (p.Gln22Lys),none provided,MedGen: C3661900
HRAS,rs121917758,G,A,"5_prime_UTR_variant,genic_upstream_transcript_variant,intron_variant,missense_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs121917758,Pathogenic,RCV000013444.26,11p15.5,NM_005343.4(HRAS):c.173C>T (p.Thr58Ile),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs121917759,G,A,"missense_variant,intron_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs121917759,Likely-Pathogenic,RCV000013445.26,11p15.5,NM_005343.4(HRAS):c.437C>T (p.Ala146Val),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs121917759,G,A,"missense_variant,intron_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs121917759,Likely-Pathogenic,RCV000419902.1,11p15.5,NM_005343.4(HRAS):c.437C>T (p.Ala146Val),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
HRAS,rs121917759,G,A,"missense_variant,intron_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs121917759,Likely-Pathogenic,RCV000426668.1,11p15.5,NM_005343.4(HRAS):c.437C>T (p.Ala146Val),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
HRAS,rs121917759,G,A,"missense_variant,intron_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs121917759,Likely-Pathogenic,RCV000427529.1,11p15.5,NM_005343.4(HRAS):c.437C>T (p.Ala146Val),Gastric adenocarcinoma,Adenocarcinoma of stomach
HRAS,rs121917759,G,A,"missense_variant,intron_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs121917759,Likely-Pathogenic,RCV000436017.1,11p15.5,NM_005343.4(HRAS):c.437C>T (p.Ala146Val),Neoplasm of uterine cervix,Uterine cervical neoplasms; Uterine cervix neoplasm
HRAS,rs121917759,G,A,"missense_variant,intron_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs121917759,Likely-Pathogenic,RCV000436710.1,11p15.5,NM_005343.4(HRAS):c.437C>T (p.Ala146Val),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
HRAS,rs121917759,G,A,"missense_variant,intron_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000 (0/478, ALFA)",6,https://www.ncbi.nlm.nih.gov/snp/rs121917759,Likely-Pathogenic,RCV000444744.1,11p15.5,NM_005343.4(HRAS):c.437C>T (p.Ala146Val),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
HRAS,rs398122809,-,dupTCT,"5_prime_UTR_variant,coding_sequence_variant,inframe_insertion,genic_upstream_transcript_variant,intron_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs398122809,Pathogenic,RCV000022798.24,11p15.5,NM_005343.4(HRAS):c.108_110dup (p.Glu37dup),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs587777239,-,dupGTCCCGCATGGCGCTGTACTC,"intron_variant,coding_sequence_variant,genic_upstream_transcript_variant,inframe_insertion,5_prime_UTR_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587777239,Pathogenic,RCV000106320.3,11p15.5,NM_005343.4(HRAS):c.187_207dup (p.Glu63_Asp69dup),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs727503093,C,T,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs727503093,Likely-Pathogenic,RCV000150834.3,11p15.5,NM_005343.4(HRAS):c.175G>A (p.Ala59Thr),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
HRAS,rs727503093,C,T,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs727503093,Likely-Pathogenic,RCV000150835.10,11p15.5,NM_005343.4(HRAS):c.175G>A (p.Ala59Thr),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs727503094,GC,AA,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs727503094,Pathogenic,RCV001577794.4,11p15.5,NM_005343.4(HRAS):c.35_36delinsTT (p.Gly12Val),none provided,MedGen: CN517202
HRAS,rs727503094,GC,AA,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs727503094,Pathogenic,RCV001732216.1,11p15.5,NM_005343.4(HRAS):c.35_36delinsTT (p.Gly12Val),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs727503094,GC,AG,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs727503094,Pathogenic,RCV000157929.1,11p15.5,NM_005343.4(HRAS):c.35_36delinsCT (p.Gly12Ala),none provided,MedGen: CN517202
HRAS,rs727503094,GC,AT,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs727503094,Pathogenic,RCV001678586.2,11p15.5,NM_005343.4(HRAS):c.35_36delinsAT (p.Gly12Asp),none provided,MedGen: CN517202
HRAS,rs727503094,GC,TA,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs727503094,Pathogenic,RCV000322736.1,11p15.5,NM_005343.4(HRAS):c.35_36delinsTA (p.Gly12Val),none provided,MedGen: CN517202
HRAS,rs727503094,GC,TT,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs727503094,Likely-Pathogenic,RCV000150836.3,11p15.5,NM_005343.4(HRAS):c.35_36delinsAA (p.Gly12Glu),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs727503094,GC,TT,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs727503094,Pathogenic,RCV000255809.1,11p15.5,NM_005343.4(HRAS):c.35_36delinsAA (p.Gly12Glu),none provided,MedGen: C3661900
HRAS,rs727504424,G,A,"intron_variant,coding_sequence_variant,synonymous_variant,genic_upstream_transcript_variant,5_prime_UTR_variant","A=0.000030 (8/264690, TOPMED).A=0.000088 (22/250330, GnomAD_exome).A=0.000043 (6/140210, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs727504424,Likely-Pathogenic,RCV001813428.1,11p15.5,NM_005343.4(HRAS):c.36C>T (p.Gly12=),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
HRAS,rs727504747,GC,AG,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,5_prime_UTR_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs727504747,Likely-Pathogenic,RCV000156047.3,11p15.5,NM_005343.4(HRAS):c.175_176delinsCT (p.Ala59Leu),"Costello syndrome (CSTLO)
                    ",Faciocutaneoskeletal syndrome; FCS syndrome
HRAS,rs755322824,G,C,"genic_upstream_transcript_variant,intron_variant,coding_sequence_variant,5_prime_UTR_variant,missense_variant","C=0.000004 (1/264690, TOPMED).C=0.000008 (2/251280, GnomAD_exome).C=0.00005 (1/19668, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs755322824,Likely-Pathogenic,RCV000207497.1,11p15.5,NM_005343.4(HRAS):c.266C>G (p.Ser89Cys),none provided,MedGen: CN517202
HRAS,rs770648642,G,C,"intron_variant,coding_sequence_variant,missense_variant,genic_upstream_transcript_variant,3_prime_UTR_variant,synonymous_variant","A=0.000012 (3/248234, GnomAD_exome).A=0.000008 (1/119472, ExAC).A=0.00042 (12/28258, 14KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs770648642,Pathogenic,RCV001563014.2,11p15.5,NM_005343.4(HRAS):c.468C>G (p.Phe156Leu),none provided,MedGen: C3661900
HRAS,rs1057519855,CT,AC,"intron_variant,genic_upstream_transcript_variant,missense_variant,coding_sequence_variant,5_prime_UTR_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519855,Likely-Pathogenic,RCV000435225.1,11p15.5,NM_005343.4(HRAS):c.182_183delinsGT (p.Gln61Arg),Neoplasm,Neoplasms; Neoplasm (disease)
HRAS,rs1057519855,CT,TC,"intron_variant,genic_upstream_transcript_variant,missense_variant,coding_sequence_variant,5_prime_UTR_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519855,Likely-Pathogenic,RCV000418005.1,11p15.5,NM_005343.4(HRAS):c.182_183delinsGA (p.Gln61Arg),Neoplasm,Neoplasms; Neoplasm (disease)
IKZF1,rs770551610,G,A,"genic_downstream_transcript_variant,coding_sequence_variant,missense_variant,intron_variant","A=0.000008 (1/118008, ExAC).A=0.00000 (0/11862, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs770551610#publications,Pathogenic,RCV000210346.3,7p12.2,NM_006060.6(IKZF1):c.485G>A (p.Arg162Gln),Pancytopenia due to IKZF1 mutations,"Immunodeficiency, common variable, 13"
IKZF1,rs770551610,G,T,"genic_downstream_transcript_variant,coding_sequence_variant,missense_variant,intron_variant","A=0.000008 (1/118008, ExAC).A=0.00000 (0/11862, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs770551610#publications,Pathogenic,RCV000210351.3,7p12.2,NM_006060.6(IKZF1):c.485G>T (p.Arg162Leu),Pancytopenia due to IKZF1 mutations,"Immunodeficiency, common variable, 13"
IKZF1,rs869312883,A,G,"intron_variant,missense_variant,coding_sequence_variant,genic_downstream_transcript_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs869312883,Pathogenic,RCV000210348.3,7p12.2,NM_006060.6(IKZF1):c.629A>G (p.Tyr210Cys),Pancytopenia due to IKZF1 mutations,"Immunodeficiency, common variable, 13"
IKZF1,rs869312884,A,G,"intron_variant,missense_variant,coding_sequence_variant,genic_downstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs869312884,Pathogenic,RCV000210347.3,7p12.2,NM_006060.6(IKZF1):c.500A>G (p.His167Arg),Pancytopenia due to IKZF1 mutations,"Immunodeficiency, common variable, 13"
IKZF1,rs869312884,A,G,"intron_variant,missense_variant,coding_sequence_variant,genic_downstream_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs869312884,Pathogenic,RCV001027579.1,7p12.2,NM_006060.6(IKZF1):c.500A>G (p.His167Arg),Inherited Immunodeficiency Diseases,MeSH: D000081207; MedGen: C5197805
IKZF1,rs869312885,G,A,"intron_variant,missense_variant,coding_sequence_variant,genic_downstream_transcript_variant","A=0.000004 (1/246214, GnomAD_exome).A=0.00006 (1/16758, 8.3KJPN)",1,https://www.ncbi.nlm.nih.gov/snp/rs869312885,Pathogenic,RCV000210350.3,7p12.2,NM_006060.6(IKZF1):c.551G>A (p.Arg184Gln),Pancytopenia due to IKZF1 mutations,"Immunodeficiency, common variable, 13"
KIF1B,rs121908160,A,T,"coding_sequence_variant,missense_variant","T=0.00000 (0/78692, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908160#publications,Pathogenic,RCV000004921.4,1p36.22,NM_001365951.3(KIF1B):c.293A>T (p.Gln98Leu),Charcot-Marie-Tooth disease type 2A1,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1; CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1; See all synonyms [MedGen]"
KIF1B,rs121908161,A,T,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121908161,Risk-Factor,RCV000004922.2,1p36.22,NM_001365951.3(KIF1B):c.2075A>T (p.Glu692Val),"Neuroblastoma, susceptibility to, 1",Neuroblastoma 1
KIF1B,rs121908162,C,T,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant","T=0.000570 (151/264690, TOPMED).T=0.000608 (153/251484, GnomAD_exome).T=0.000758 (151/199290, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121908162,Risk-Factor,RCV000004923.4,1p36.22,NM_001365951.3(KIF1B):c.2618C>T (p.Thr873Ile),"Neuroblastoma, susceptibility to, 1",Neuroblastoma 1
KIF1B,rs121908163,C,T,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant","T=0.000144 (38/264690, TOPMED).T=0.000199 (50/251166, GnomAD_exome).T=0.000057 (8/140228, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908163,Risk-Factor,RCV000004924.2,1p36.22,NM_001365951.3(KIF1B):c.3787C>T (p.Pro1263Ser),"Neuroblastoma, susceptibility to, 1",Neuroblastoma 1
KIF1B,rs121908163,C,T,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant","T=0.000144 (38/264690, TOPMED).T=0.000199 (50/251166, GnomAD_exome).T=0.000057 (8/140228, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908163,Likely-Pathogenic,RCV000490400.1,1p36.22,NM_001365951.3(KIF1B):c.3787C>T (p.Pro1263Ser),"Neuroblastoma (NB)
                    ",MONDO: MONDO:0005072; MeSH: D009447; MedGen: C0027819; Orphanet: 635; Human Phenotype Ontology: HP:0003006
KIF1B,rs121908164,G,A,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant","A=0.000004 (1/264690, TOPMED).A=0.000004 (1/251448, GnomAD_exome).A=0.000007 (1/140196, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908164,Pathogenic,RCV000004925.2,1p36.22,NM_001365951.3(KIF1B):c.4580G>A (p.Ser1527Asn),Pheochromocytoma,Chromaffinoma; Chromaffin paraganglioma; Chromaffin tumor; See all synonyms [MedGen]
KIF1B,rs121908164,G,A,"coding_sequence_variant,missense_variant,genic_downstream_transcript_variant","A=0.000004 (1/264690, TOPMED).A=0.000004 (1/251448, GnomAD_exome).A=0.000007 (1/140196, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908164,Risk-Factor,RCV000004926.2,1p36.22,NM_001365951.3(KIF1B):c.4580G>A (p.Ser1527Asn),"Neuroblastoma, susceptibility to, 1 (NBLST1)
                    ",Neuroblastoma 1
KIT,rs3822214,A,C,"missense_variant,coding_sequence_variant","C=0.091938 (27896/303422, ALFA).C=0.079417 (21021/264690, TOPMED).C=0.077266 (10833/140204, GnomAD)",11,https://www.ncbi.nlm.nih.gov/snp/rs3822214#publications,Pathogenic,RCV001255636.1,4q12,NM_000222.3(KIT):c.1621A>C (p.Met541Leu),Lip and oral cavity carcinoma,MONDO: MONDO:0023644; MedGen: C0220641
KIT,rs28933371,T,G,"coding_sequence_variant,missense_variant","G=0.00003 (2/78664, PAGE_STUDY).G=0.002 (1/658, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs28933371,Pathogenic,RCV000014878.25,4q12,NM_000222.3(KIT):c.1751T>G (p.Phe584Cys),Piebaldism,Piebald skin depigmentation
KIT,rs121913235,T,A,"missense_variant,coding_sequence_variant",None,18,https://www.ncbi.nlm.nih.gov/snp/rs121913235,Pathogenic,RCV000421211.1,4q12,NM_000222.3(KIT):c.1669T>A (p.Trp557Arg),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913235,T,A,"missense_variant,coding_sequence_variant",None,18,https://www.ncbi.nlm.nih.gov/snp/rs121913235,Likely-Pathogenic,RCV000431900.1,4q12,NM_000222.3(KIT):c.1669T>A (p.Trp557Arg),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913235,T,C,"missense_variant,coding_sequence_variant",None,18,https://www.ncbi.nlm.nih.gov/snp/rs121913235,Pathogenic,RCV000425331.1,4q12,NM_000222.3(KIT):c.1669T>C (p.Trp557Arg),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs121913235,T,C,"missense_variant,coding_sequence_variant",None,18,https://www.ncbi.nlm.nih.gov/snp/rs121913235,Likely-Pathogenic,RCV000432558.8,4q12,NM_000222.3(KIT):c.1669T>C (p.Trp557Arg),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913235,T,C,"missense_variant,coding_sequence_variant",None,18,https://www.ncbi.nlm.nih.gov/snp/rs121913235,Pathogenic,RCV000442970.1,4q12,NM_000222.3(KIT):c.1669T>C (p.Trp557Arg),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913235,T,G,"missense_variant,coding_sequence_variant",None,18,https://www.ncbi.nlm.nih.gov/snp/rs121913235,Likely-Pathogenic,RCV000417409.1,4q12,NM_000222.3(KIT):c.1669T>G (p.Trp557Gly),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913505,G,A,"missense_variant,coding_sequence_variant","A=0.000023 (6/264690, TOPMED).A=0.000020 (5/251126, GnomAD_exome).A=0.000025 (3/121374, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs121913505,Likely-Pathogenic,RCV000422536.1,4q12,NM_000222.3(KIT):c.154G>A (p.Asp52Asn),Neoplasm,Neoplasms; Neoplasm (disease)
KIT,rs121913506,G,C,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Pathogenic,RCV000014877.5,4q12,NM_000222.3(KIT):c.2446G>C (p.Asp816His),"Germ cell tumor of testis (TGCT)
                    ","GERM CELL TUMOR, SOMATIC; Testicular germ cell tumor"
KIT,rs121913506,G,C,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Pathogenic,RCV000379347.4,4q12,NM_000222.3(KIT):c.2446G>C (p.Asp816His),none provided,MedGen: CN517202
KIT,rs121913506,G,C,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Likely-Pathogenic,RCV000418294.1,4q12,NM_000222.3(KIT):c.2446G>C (p.Asp816His),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
KIT,rs121913506,G,C,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Pathogenic,RCV000428990.1,4q12,NM_000222.3(KIT):c.2446G>C (p.Asp816His),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913506,G,C,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Likely-Pathogenic,RCV000439677.1,4q12,NM_000222.3(KIT):c.2446G>C (p.Asp816His),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913506,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Pathogenic,RCV000014874.29,4q12,NM_000222.3(KIT):c.2446G>T (p.Asp816Tyr),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KIT,rs121913506,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Likely-Pathogenic,RCV000422151.1,4q12,NM_000222.3(KIT):c.2446G>T (p.Asp816Tyr),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913506,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Likely-Pathogenic,RCV000422812.1,4q12,NM_000222.3(KIT):c.2446G>T (p.Asp816Tyr),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
KIT,rs121913506,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Likely-Pathogenic,RCV000429574.1,4q12,NM_000222.3(KIT):c.2446G>T (p.Asp816Tyr),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913506,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/140180, GnomAD).A=0.00000 (0/14050, ALFA)",16,https://www.ncbi.nlm.nih.gov/snp/rs121913506,Pathogenic,RCV000663344.2,4q12,NM_000222.3(KIT):c.2446G>T (p.Asp816Tyr),"MASTOCYTOSIS, CUTANEOUS AND SYSTEMIC, SOMATIC",MedGen: C4749139
KIT,rs121913507,A,T,"missense_variant,coding_sequence_variant","T=0.00005 (1/21346, ALFA)",21,https://www.ncbi.nlm.nih.gov/snp/rs121913507,Likely-Pathogenic,RCV000014864.24,4q12,NM_000222.3(KIT):c.2447A>T (p.Asp816Val),Mast cell leukemia,MONDO: MONDO:0020334; MeSH: D007946; MedGen: C0023461
KIT,rs121913507,A,T,"missense_variant,coding_sequence_variant","T=0.00005 (1/21346, ALFA)",21,https://www.ncbi.nlm.nih.gov/snp/rs121913507,Likely-Pathogenic,RCV000443179.1,4q12,NM_000222.3(KIT):c.2447A>T (p.Asp816Val),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
KIT,rs121913507,A,T,"missense_variant,coding_sequence_variant","T=0.00005 (1/21346, ALFA)",21,https://www.ncbi.nlm.nih.gov/snp/rs121913507,Pathogenic,RCV000444150.1,4q12,NM_000222.3(KIT):c.2447A>T (p.Asp816Val),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KIT,rs121913507,A,T,"missense_variant,coding_sequence_variant","T=0.00005 (1/21346, ALFA)",21,https://www.ncbi.nlm.nih.gov/snp/rs121913507,Pathogenic,RCV000656673.3,4q12,NM_000222.3(KIT):c.2447A>T (p.Asp816Val),"MAST CELL LEUKEMIA, SOMATIC",
KIT,rs121913507,A,T,"missense_variant,coding_sequence_variant","T=0.00005 (1/21346, ALFA)",21,https://www.ncbi.nlm.nih.gov/snp/rs121913507,Pathogenic,RCV000656674.3,4q12,NM_000222.3(KIT):c.2447A>T (p.Asp816Val),"MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC DISORDER, SOMATIC",
KIT,rs121913507,A,T,"missense_variant,coding_sequence_variant","T=0.00005 (1/21346, ALFA)",21,https://www.ncbi.nlm.nih.gov/snp/rs121913507,Pathogenic,RCV000656675.3,4q12,NM_000222.3(KIT):c.2447A>T (p.Asp816Val),"MASTOCYTOSIS, SYSTEMIC, SOMATIC",
KIT,rs121913507,A,T,"missense_variant,coding_sequence_variant","T=0.00005 (1/21346, ALFA)",21,https://www.ncbi.nlm.nih.gov/snp/rs121913507,Pathogenic,RCV001269832.1,4q12,NM_000222.3(KIT):c.2447A>T (p.Asp816Val),none provided,MedGen: CN517202
KIT,rs121913509,G,A,"missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs121913509,Pathogenic,RCV000014876.27,4q12,NM_000222.3(KIT):c.2515G>A (p.Glu839Lys),Mastocytosis,Mast cell disease
KIT,rs121913509,G,A,"missense_variant,coding_sequence_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs121913509,Likely-Pathogenic,RCV000428235.1,4q12,NM_000222.3(KIT):c.2515G>A (p.Glu839Lys),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913512,A,G,"missense_variant,stop_gained,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",14,https://www.ncbi.nlm.nih.gov/snp/rs121913512,Pathogenic,RCV000014880.27,4q12,NM_000222.3(KIT):c.1924A>G (p.Lys642Glu),"Gastrointestinal stromal tumor, familial",MedGen: C2674636
KIT,rs121913512,A,G,"missense_variant,stop_gained,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",14,https://www.ncbi.nlm.nih.gov/snp/rs121913512,Pathogenic,RCV000418637.5,4q12,NM_000222.3(KIT):c.1924A>G (p.Lys642Glu),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913512,A,G,"missense_variant,stop_gained,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",14,https://www.ncbi.nlm.nih.gov/snp/rs121913512,Likely-Pathogenic,RCV000419318.1,4q12,NM_000222.3(KIT):c.1924A>G (p.Lys642Glu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913512,A,G,"missense_variant,stop_gained,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",14,https://www.ncbi.nlm.nih.gov/snp/rs121913512,Likely-Pathogenic,RCV000428892.1,4q12,NM_000222.3(KIT):c.1924A>G (p.Lys642Glu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
KIT,rs121913512,A,G,"missense_variant,stop_gained,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",14,https://www.ncbi.nlm.nih.gov/snp/rs121913512,Likely-Pathogenic,RCV000429594.1,4q12,NM_000222.3(KIT):c.1924A>G (p.Lys642Glu),Gastric adenocarcinoma,Adenocarcinoma of stomach
KIT,rs121913512,A,G,"missense_variant,stop_gained,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",14,https://www.ncbi.nlm.nih.gov/snp/rs121913512,Likely-Pathogenic,RCV000436303.1,4q12,NM_000222.3(KIT):c.1924A>G (p.Lys642Glu),Hematologic neoplasm,Hematologic cancer; Hematological neoplasm; Hematological malignancies
KIT,rs121913513,T,C,"missense_variant,coding_sequence_variant",None,16,https://www.ncbi.nlm.nih.gov/snp/rs121913513,Pathogenic,RCV000426330.1,4q12,NM_000222.3(KIT):c.1727T>C (p.Leu576Pro),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913513,T,C,"missense_variant,coding_sequence_variant",None,16,https://www.ncbi.nlm.nih.gov/snp/rs121913513,Likely-Pathogenic,RCV000433543.2,4q12,NM_000222.3(KIT):c.1727T>C (p.Leu576Pro),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913513,T,C,"missense_variant,coding_sequence_variant",None,16,https://www.ncbi.nlm.nih.gov/snp/rs121913513,Pathogenic,RCV000443552.1,4q12,NM_000222.3(KIT):c.1727T>C (p.Leu576Pro),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs121913514,T,A,"missense_variant,synonymous_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs121913514,Likely-Pathogenic,RCV000429954.1,4q12,NM_000222.3(KIT):c.2466T>A (p.Asn822Lys),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KIT,rs121913514,T,A,"missense_variant,synonymous_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs121913514,Pathogenic,RCV000436687.1,4q12,NM_000222.3(KIT):c.2466T>A (p.Asn822Lys),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913514,T,A,"missense_variant,synonymous_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs121913514,Pathogenic,RCV001269701.1,4q12,NM_000222.3(KIT):c.2466T>A (p.Asn822Lys),none provided,MedGen: CN517202
KIT,rs121913514,T,G,"missense_variant,synonymous_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs121913514,Likely-Pathogenic,RCV000419001.1,4q12,NM_000222.3(KIT):c.2466T>G (p.Asn822Lys),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913514,T,G,"missense_variant,synonymous_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs121913514,Pathogenic,RCV000429190.1,4q12,NM_000222.3(KIT):c.2466T>G (p.Asn822Lys),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913514,T,G,"missense_variant,synonymous_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs121913514,Likely-Pathogenic,RCV000439434.1,4q12,NM_000222.3(KIT):c.2466T>G (p.Asn822Lys),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KIT,rs121913514,T,G,"missense_variant,synonymous_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs121913514,Pathogenic,RCV001269906.1,4q12,NM_000222.3(KIT):c.2466T>G (p.Asn822Lys),none provided,MedGen: CN517202
KIT,rs121913516,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/264690, TOPMED).T=0.000004 (1/251050, GnomAD_exome).T=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs121913516,Likely-Pathogenic,RCV000421498.1,4q12,NM_000222.3(KIT):c.2009C>T (p.Thr670Ile),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913517,T,A,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Pathogenic-Likely-Pathogenic,RCV000014870.6,4q12,NM_000222.3(KIT):c.1676T>A (p.Val559Asp),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913517,T,A,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Pathogenic,RCV000419360.1,4q12,NM_000222.3(KIT):c.1676T>A (p.Val559Asp),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913517,T,C,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Pathogenic,RCV000014879.27,4q12,NM_000222.3(KIT):c.1676T>C (p.Val559Ala),"Gastrointestinal stromal tumor, familial",MedGen: C2674636
KIT,rs121913517,T,C,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Pathogenic,RCV000420045.1,4q12,NM_000222.3(KIT):c.1676T>C (p.Val559Ala),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs121913517,T,C,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Likely-Pathogenic,RCV000430728.1,4q12,NM_000222.3(KIT):c.1676T>C (p.Val559Ala),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913517,T,C,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Likely-Pathogenic,RCV000437270.1,4q12,NM_000222.3(KIT):c.1676T>C (p.Val559Ala),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913517,T,C,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Pathogenic,RCV000663345.1,4q12,NM_000222.3(KIT):c.1676T>C (p.Val559Ala),Cutaneous mastocytosis,"MASTOCYTOSIS, MACULOPAPULAR CUTANEOUS; MASTOCYTOSIS, DIFFUSE CUTANEOUS"
KIT,rs121913517,T,G,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Pathogenic,RCV000420731.1,4q12,NM_000222.3(KIT):c.1676T>G (p.Val559Gly),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913517,T,G,"missense_variant,coding_sequence_variant",None,26,https://www.ncbi.nlm.nih.gov/snp/rs121913517,Likely-Pathogenic,RCV000441453.1,4q12,NM_000222.3(KIT):c.1676T>G (p.Val559Gly),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913520,G,A,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs121913520,Likely-Pathogenic,RCV000426761.1,4q12,NM_000222.3(KIT):c.1675G>A (p.Val559Ile),Myeloproliferative neoplasm,MONDO: MONDO:0020076; MedGen: C1292778
KIT,rs121913521,T,A,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs121913521,Pathogenic,RCV000421479.1,4q12,NM_000222.3(KIT):c.1679T>A (p.Val560Asp),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913521,T,A,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs121913521,Likely-Pathogenic,RCV000438714.1,4q12,NM_000222.3(KIT):c.1679T>A (p.Val560Asp),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913521,T,C,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs121913521,Pathogenic,RCV000432167.1,4q12,NM_000222.3(KIT):c.1679T>C (p.Val560Ala),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913521,T,G,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs121913521,Pathogenic,RCV000422100.1,4q12,NM_000222.3(KIT):c.1679T>G (p.Val560Gly),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913521,T,G,"missense_variant,coding_sequence_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs121913521,Likely-Pathogenic,RCV000439325.1,4q12,NM_000222.3(KIT):c.1679T>G (p.Val560Gly),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913523,T,A,"missense_variant,coding_sequence_variant",None,11,https://www.ncbi.nlm.nih.gov/snp/rs121913523,Likely-Pathogenic,RCV000439135.1,4q12,NM_000222.3(KIT):c.1961T>A (p.Val654Glu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913523,T,C,"missense_variant,coding_sequence_variant",None,11,https://www.ncbi.nlm.nih.gov/snp/rs121913523,Pathogenic,RCV000427620.1,4q12,NM_000222.3(KIT):c.1961T>C (p.Val654Ala),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913524,T,C,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913524,Likely-Pathogenic,RCV000440432.1,4q12,NM_000222.3(KIT):c.2474T>C (p.Val825Ala),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913679,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/78700, PAGE_STUDY).A=0.002 (1/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121913679,Pathogenic,RCV000014855.22,4q12,NM_000222.3(KIT):c.1990G>A (p.Gly664Arg),Piebaldism,Piebald skin depigmentation
KIT,rs121913680,G,A,"missense_variant,stop_gained,coding_sequence_variant","A=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs121913680,Pathogenic,RCV000014861.23,4q12,NM_000222.3(KIT):c.1747G>A (p.Glu583Lys),Piebaldism,Piebald skin depigmentation
KIT,rs121913682,A,G,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913682,Pathogenic,RCV000014867.27,4q12,NM_000222.3(KIT):c.2459A>G (p.Asp820Gly),"MASTOCYTOSIS, SYSTEMIC, SOMATIC",
KIT,rs121913682,A,T,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121913682,Likely-Pathogenic,RCV000425679.1,4q12,NM_000222.3(KIT):c.2459A>T (p.Asp820Val),Systemic mast cell disease,Systemic mastocytosis
KIT,rs121913684,A,G,"missense_variant,stop_gained,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913684,Pathogenic,RCV000014872.23,4q12,NM_000222.3(KIT):c.2386A>G (p.Arg796Gly),Piebaldism with sensorineural deafness,MedGen: C4016294
KIT,rs121913685,TTGTTG,del(TTG)2,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Pathogenic,RCV000014858.6,4q12,NM_000222.3(KIT):c.1676_1681del (p.Val559_Val560del),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913685,TTGTTG,delTTG,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Pathogenic,RCV000014873.26,4q12,NM_000222.3(KIT):c.1676TTG[1] (p.Val560del),"Gastrointestinal stromal tumor, familial",MedGen: C2674636
KIT,rs121913685,TTGTTG,delTTG,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Pathogenic,RCV000428023.1,4q12,NM_000222.3(KIT):c.1676TTG[1] (p.Val560del),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs121913685,TTGTTG,delTTG,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Likely-Pathogenic,RCV000432801.1,4q12,NM_000222.3(KIT):c.1676TTG[1] (p.Val560del),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs121913687,A,C,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913687,Pathogenic,RCV000014875.26,4q12,NM_000222.3(KIT):c.2539A>C (p.Thr847Pro),Piebaldism,Piebald skin depigmentation
KIT,rs200375589,G,C,"missense_variant,coding_sequence_variant,synonymous_variant","A=0.000121 (32/264690, TOPMED).A=0.000060 (15/250938, GnomAD_exome).A=0.000157 (22/140252, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs200375589,Pathogenic,RCV000443034.1,4q12,NM_000222.3(KIT):c.1674G>C (p.Lys558Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs200375589,G,T,"missense_variant,coding_sequence_variant,synonymous_variant","A=0.000121 (32/264690, TOPMED).A=0.000060 (15/250938, GnomAD_exome).A=0.000157 (22/140252, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs200375589,Likely-Pathogenic,RCV000426003.1,4q12,NM_000222.3(KIT):c.1674G>T (p.Lys558Asn),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs200375589,G,T,"missense_variant,coding_sequence_variant,synonymous_variant","A=0.000121 (32/264690, TOPMED).A=0.000060 (15/250938, GnomAD_exome).A=0.000157 (22/140252, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs200375589,Pathogenic,RCV000436617.1,4q12,NM_000222.3(KIT):c.1674G>T (p.Lys558Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs387907217,T,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs387907217,Pathogenic,RCV000029170.26,4q12,NM_000222.3(KIT):c.1859T>C (p.Val620Ala),"Piebaldism, progressive",MedGen: C4016297
KIT,rs587776804,CCATGTATGAAGTAC,delCCATGTATGAAGTAC,"inframe_deletion,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs587776804,Pathogenic,RCV000014868.6,4q12,NM_000222.3(KIT):c.1652_1666del (p.Pro551_Val555del),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs763308199,C,T,"missense_variant,coding_sequence_variant","T=0.000016 (4/250678, GnomAD_exome).T=0.000017 (2/121070, ExAC).T=0.00003 (1/35418, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs763308199,Pathogenic,RCV000435524.1,4q12,NM_000222.3(KIT):c.2089C>T (p.His697Tyr),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs794726671,T,G,"missense_variant,synonymous_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs794726671,Pathogenic,RCV000014857.27,4q12,NM_000222.3(KIT):c.1752T>G (p.Phe584Leu),"Partial albinism (PBT)
                    ",Piebaldism
KIT,rs869025568,TGGAAG,delTGGAAG,"inframe_deletion,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs869025568,Likely-Pathogenic,RCV000208566.1,4q12,NM_000222.3(KIT):c.1669_1674del (p.Trp557_Lys558del),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs993022333,A,T,"coding_sequence_variant,missense_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs993022333,Likely-Pathogenic,RCV000427071.1,4q12,NM_000222.3(KIT):c.2465A>T (p.Asn822Ile),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs993022333,A,T,"coding_sequence_variant,missense_variant","C=0.000004 (1/264690, TOPMED).C=0.00000 (0/14050, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs993022333,Pathogenic,RCV000437313.1,4q12,NM_000222.3(KIT):c.2465A>T (p.Asn822Ile),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519701,G,A,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519701,Pathogenic,RCV000419707.1,4q12,NM_000222.3(KIT):c.1468G>A (p.Glu490Lys),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs1057519702,T,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519702,Pathogenic,RCV000430398.1,4q12,NM_000222.3(KIT):c.1510T>C (p.Phe504Leu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519703,A,C,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519703,Pathogenic,RCV000441099.1,4q12,NM_000222.3(KIT):c.1650A>C (p.Lys550Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519703,A,T,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519703,Pathogenic,RCV000423846.1,4q12,NM_000222.3(KIT):c.1650A>T (p.Lys550Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519704,T,A,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519704,Pathogenic,RCV000434537.1,4q12,NM_000222.3(KIT):c.1657T>A (p.Tyr553Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519704,T,A,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519704,Pathogenic,RCV000438425.1,4q12,NM_000222.3(KIT):c.1657T>A (p.Tyr553Asn),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs1057519705,A,G,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519705,Pathogenic,RCV000432830.1,4q12,NM_000222.3(KIT):c.1696A>G (p.Asn566Asp),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519706,T,G,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519706,Pathogenic,RCV000442809.1,4q12,NM_000222.3(KIT):c.1706T>G (p.Val569Gly),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519707,A,G,"coding_sequence_variant,missense_variant","G=0.000004 (1/264690, TOPMED).G=0.000007 (1/140232, GnomAD).G=0.00004 (1/28258, 14KJPN)",2,https://www.ncbi.nlm.nih.gov/snp/rs1057519707,Pathogenic,RCV000438326.1,4q12,NM_000222.3(KIT):c.1964A>G (p.Asn655Ser),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519708,T,A,"synonymous_variant,coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519708,Pathogenic,RCV000417636.1,4q12,NM_000222.3(KIT):c.1965T>A (p.Asn655Lys),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519708,T,A,"synonymous_variant,coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519708,Likely-Pathogenic,RCV000808244.4,4q12,NM_000222.3(KIT):c.1965T>A (p.Asn655Lys),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057519708,T,G,"synonymous_variant,coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519708,Pathogenic,RCV000428319.1,4q12,NM_000222.3(KIT):c.1965T>G (p.Asn655Lys),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519708,T,G,"synonymous_variant,coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519708,Likely-Pathogenic,RCV000549644.7,4q12,NM_000222.3(KIT):c.1965T>G (p.Asn655Lys),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057519709,GA,AT,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519709,Pathogenic,RCV000432380.1,4q12,NM_000222.3(KIT):c.2446_2447delinsAT (p.Asp816Ile),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KIT,rs1057519710,G,C,"coding_sequence_variant,missense_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs1057519710,Pathogenic,RCV000427793.1,4q12,NM_000222.3(KIT):c.2458G>C (p.Asp820His),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519710,G,T,"coding_sequence_variant,missense_variant",None,9,https://www.ncbi.nlm.nih.gov/snp/rs1057519710,Pathogenic,RCV000437969.1,4q12,NM_000222.3(KIT):c.2458G>T (p.Asp820Tyr),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519711,T,A,"synonymous_variant,coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519711,Pathogenic,RCV000442445.1,4q12,NM_000222.3(KIT):c.2460T>A (p.Asp820Glu),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs1057519713,G,C,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519713,Pathogenic,RCV000421785.1,4q12,NM_000222.3(KIT):c.2485G>C (p.Ala829Pro),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KIT,rs1057519713,G,C,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519713,Likely-Pathogenic,RCV000428554.1,4q12,NM_000222.3(KIT):c.2485G>C (p.Ala829Pro),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057519761,T,G,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519761,Likely-Pathogenic,RCV000439224.1,4q12,NM_000222.3(KIT):c.2467T>G (p.Tyr823Asp),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057519907,A,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519907,Likely-Pathogenic,RCV000428962.1,4q12,NM_000222.3(KIT):c.1926A>C (p.Lys642Asn),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
KIT,rs1057519907,A,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519907,Likely-Pathogenic,RCV000439220.1,4q12,NM_000222.3(KIT):c.1926A>C (p.Lys642Asn),Gastric adenocarcinoma,Adenocarcinoma of stomach
KIT,rs1057520031,A,C,"stop_gained,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057520031,Likely-Pathogenic,RCV000428356.1,4q12,NM_000222.3(KIT):c.1672A>C (p.Lys558Gln),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057520031,A,G,"stop_gained,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057520031,Likely-Pathogenic,RCV000429441.1,4q12,NM_000222.3(KIT):c.1672A>G (p.Lys558Glu),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057520032,G,A,"stop_gained,coding_sequence_variant,missense_variant","A=0.000004 (1/250960, GnomAD_exome).A=0.00005 (1/21382, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057520032,Pathogenic,RCV000541020.2,4q12,NM_000222.3(KIT):c.1670G>A (p.Trp557Ter),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057520032,G,A,"stop_gained,coding_sequence_variant,missense_variant","A=0.000004 (1/250960, GnomAD_exome).A=0.00005 (1/21382, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057520032,Pathogenic,RCV000761057.1,4q12,NM_000222.3(KIT):c.1670G>A (p.Trp557Ter),B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged,MedGen: C2698309
KIT,rs1057520033,G,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057520033,Likely-Pathogenic,RCV000439662.1,4q12,NM_000222.3(KIT):c.1671G>C (p.Trp557Cys),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1057520035,GG,TT,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057520035,Likely-Pathogenic,RCV000428828.1,4q12,NM_000222.3(KIT):c.1670_1671delinsTT (p.Trp557Phe),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs1131692239,CTTATGATC,delCTTATGATC,"coding_sequence_variant,inframe_deletion",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1131692239,Pathogenic,RCV000437669.1,4q12,NM_000222.3(KIT):c.1730_1738del (p.Pro577_Asp579del),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs121913685,TTGTTG,del(TTG)2,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Pathogenic,RCV000014858.6,4q12,NM_000222.3(KIT):c.1676_1681del (p.Val559_Val560del),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KIT,rs121913685,TTGTTG,delTTG,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Pathogenic,RCV000014873.26,4q12,NM_000222.3(KIT):c.1676TTG[1] (p.Val560del),"Gastrointestinal stromal tumor, familial",MedGen: C2674636
KIT,rs121913685,TTGTTG,delTTG,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Pathogenic,RCV000428023.1,4q12,NM_000222.3(KIT):c.1676TTG[1] (p.Val560del),Thymoma,MONDO: MONDO:0006456; MeSH: D013945; MedGen: C0040100; Human Phenotype Ontology: HP:0100522
KIT,rs121913685,TTGTTG,delTTG,"inframe_deletion,coding_sequence_variant",None,7,https://www.ncbi.nlm.nih.gov/snp/rs121913685,Likely-Pathogenic,RCV000432801.1,4q12,NM_000222.3(KIT):c.1676TTG[1] (p.Val560del),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
KITLG,rs121918653,T,C,"missense_variant,coding_sequence_variant","C=0.000 (0/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs121918653#publications,Pathogenic,RCV000013661.26,12q21.32,NM_000899.5(KITLG):c.107A>G (p.Asn36Ser),"Hyperpigmentation with or without hypopigmentation, familial progressive","Hyperpigmentation, familial progressive, 2; Congenital hypomelanotic and hypermelanotic macules; MELANOSIS UNIVERSALIS HEREDITARIA"
KITLG,rs730882156,A,G,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs730882156,Pathogenic,RCV000162036.4,12q21.32,NM_000899.5(KITLG):c.98T>C (p.Val33Ala),"Hyperpigmentation with or without hypopigmentation, familial progressive","Hyperpigmentation, familial progressive, 2; Congenital hypomelanotic and hypermelanotic macules; MELANOSIS UNIVERSALIS HEREDITARIA"
KITLG,rs730882157,T,G,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs730882157,Pathogenic,RCV000162037.4,12q21.32,NM_000899.5(KITLG):c.100A>C (p.Thr34Pro),"Hyperpigmentation with or without hypopigmentation, familial progressive","Hyperpigmentation, familial progressive, 2; Congenital hypomelanotic and hypermelanotic macules; MELANOSIS UNIVERSALIS HEREDITARIA"
KITLG,rs864309654,AAT,delAAT,"coding_sequence_variant,inframe_indel",None,1,https://www.ncbi.nlm.nih.gov/snp/rs864309654,Pathogenic,RCV000203244.3,12q21.32,NM_000899.5(KITLG):c.200_202del (p.His67_Cys68delinsArg),Autosomal dominant nonsyndromic hearing loss 69,"Deafness, autosomal dominant 69; Deafness, autosomal dominant 69, unilateral or asymmetric"
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Pathogenic,RCV000038259.5,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Pathogenic,RCV000417543.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000420404.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000421965.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000423293.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000423952.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000429878.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000430651.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Malignant neoplasm of body of uterus,MedGen: C0153574
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000433108.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),B-cell chronic lymphocytic leukemia,"Chronic lymphocytic leukemia; Leukemia, B-cell, chronic; Chronic lymphatic leukemia"
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000433564.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000435442.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000440092.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000441804.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Gastric adenocarcinoma,Adenocarcinoma of stomach
KRAS,rs17851045,T,A,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000445124.1,12p12.1,NM_004985.5(KRAS):c.183A>T (p.Gln61His),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
KRAS,rs17851045,T,G,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Pathogenic,RCV000154530.5,12p12.1,NM_004985.5(KRAS):c.183A>C (p.Gln61His),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs17851045,T,G,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV000424748.1,12p12.1,NM_004985.5(KRAS):c.183A>C (p.Gln61His),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KRAS,rs17851045,T,G,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Pathogenic,RCV000444370.1,12p12.1,NM_004985.5(KRAS):c.183A>C (p.Gln61His),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs17851045,T,G,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Likely-Pathogenic,RCV001004043.1,12p12.1,NM_004985.5(KRAS):c.183A>C (p.Gln61His),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
KRAS,rs17851045,T,G,"coding_sequence_variant,synonymous_variant,missense_variant","G=0.000004 (1/251308, GnomAD_exome)",23,https://www.ncbi.nlm.nih.gov/snp/rs17851045#publications,Pathogenic,RCV002056053.3,12p12.1,NM_004985.5(KRAS):c.183A>C (p.Gln61His),none provided,MedGen: CN517202
KRAS,rs104894359,C,G,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000013416.24,12p12.1,NM_004985.5(KRAS):c.178G>C (p.Gly60Arg),"Cardiofaciocutaneous syndrome 2 (CFC2)
                    ",MONDO: MONDO:0014112; MedGen: C3809005; Orphanet: 1340; OMIM: 615278
KRAS,rs104894359,C,G,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000157935.6,12p12.1,NM_004985.5(KRAS):c.178G>C (p.Gly60Arg),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894359,C,G,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000254661.2,12p12.1,NM_004985.5(KRAS):c.178G>C (p.Gly60Arg),none provided,MedGen: C3661900
KRAS,rs104894359,C,G,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000521390.1,12p12.1,NM_004985.5(KRAS):c.178G>C (p.Gly60Arg),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
KRAS,rs104894359,C,G,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000844635.3,12p12.1,NM_004985.5(KRAS):c.178G>C (p.Gly60Arg),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894359,C,G,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV001267316.1,12p12.1,NM_004985.5(KRAS):c.178G>C (p.Gly60Arg),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
KRAS,rs104894359,C,T,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000013428.28,12p12.1,NM_033360.4(KRAS):c.178G>A (p.Gly60Ser),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs104894359,C,T,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000157934.5,12p12.1,NM_033360.4(KRAS):c.178G>A (p.Gly60Ser),none provided,MedGen: CN517202
KRAS,rs104894359,C,T,"missense_variant,coding_sequence_variant","T=0.000 (0/478, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs104894359,Pathogenic,RCV000689097.4,12p12.1,NM_033360.4(KRAS):c.178G>A (p.Gly60Ser),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000013417.26,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),"Cardiofaciocutaneous syndrome 2 (CFC2)
                    ",MONDO: MONDO:0014112; MedGen: C3809005; Orphanet: 1340; OMIM: 615278
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000013418.32,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000157940.8,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000212501.5,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),none provided,MedGen: CN517202
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000507330.6,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),AllHighlyPenetrant,MedGen: CN169374
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000523200.3,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000763307.2,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),Familial cancer of breast,"Breast cancer, familial"
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000844634.4,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894360,T,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV001267227.2,12p12.1,NM_004985.5(KRAS):c.458A>T (p.Asp153Val),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
KRAS,rs104894360,T,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Likely-Pathogenic,RCV000038274.4,12p12.1,NM_004985.5(KRAS):c.458A>G (p.Asp153Gly),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894360,T,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000157939.2,12p12.1,NM_004985.5(KRAS):c.458A>G (p.Asp153Gly),none provided,MedGen: C3661900
KRAS,rs104894360,T,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","A=0.00000 (0/78674, PAGE_STUDY)",9,https://www.ncbi.nlm.nih.gov/snp/rs104894360,Pathogenic,RCV000526276.5,12p12.1,NM_004985.5(KRAS):c.458A>G (p.Asp153Gly),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894361,T,A,"missense_variant,synonymous_variant,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.000004 (1/247720, GnomAD_exome).C=0.000007 (1/140260, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894361,Pathogenic,RCV000013425.27,12p12.1,NM_033360.4(KRAS):c.15A>T (p.Lys5Asn),"Cardiofaciocutaneous syndrome 2 (CFC2)
                    ",MONDO: MONDO:0014112; MedGen: C3809005; Orphanet: 1340; OMIM: 615278
KRAS,rs104894361,T,A,"missense_variant,synonymous_variant,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.000004 (1/247720, GnomAD_exome).C=0.000007 (1/140260, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894361,Pathogenic,RCV000520745.2,12p12.1,NM_033360.4(KRAS):c.15A>T (p.Lys5Asn),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894361,T,A,"missense_variant,synonymous_variant,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.000004 (1/247720, GnomAD_exome).C=0.000007 (1/140260, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894361,Likely-Pathogenic,RCV000623267.3,12p12.1,NM_033360.4(KRAS):c.15A>T (p.Lys5Asn),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
KRAS,rs104894361,T,G,"missense_variant,synonymous_variant,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.000004 (1/247720, GnomAD_exome).C=0.000007 (1/140260, GnomAD)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894361,Pathogenic,RCV000413067.1,12p12.1,NM_033360.4(KRAS):c.15A>C (p.Lys5Asn),none provided,MedGen: CN517202
KRAS,rs104894362,G,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","C=0.00000 (0/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894362,Pathogenic,RCV000013426.27,12p12.1,NM_033360.4(KRAS):c.*22C>G,"Cardiofaciocutaneous syndrome 2 (CFC2)
                    ",MONDO: MONDO:0014112; MedGen: C3809005; Orphanet: 1340; OMIM: 615278
KRAS,rs104894362,G,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","C=0.00000 (0/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894362,Pathogenic,RCV000157942.1,12p12.1,NM_033360.4(KRAS):c.*22C>G,none provided,MedGen: C3661900
KRAS,rs104894362,G,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","C=0.00000 (0/78700, PAGE_STUDY)",2,https://www.ncbi.nlm.nih.gov/snp/rs104894362,Pathogenic,RCV001205658.5,12p12.1,NM_033360.4(KRAS):c.*22C>G,RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894364,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/14528, ALFA)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894364,Pathogenic,RCV000013419.23,12p12.1,NM_004985.5(KRAS):c.173C>T (p.Thr58Ile),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs104894364,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/14528, ALFA)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894364,Pathogenic,RCV000157933.2,12p12.1,NM_004985.5(KRAS):c.173C>T (p.Thr58Ile),none provided,MedGen: C3661900
KRAS,rs104894364,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/14528, ALFA)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894364,Pathogenic,RCV000211785.4,12p12.1,NM_004985.5(KRAS):c.173C>T (p.Thr58Ile),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894364,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/14528, ALFA)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894364,Pathogenic,RCV000704828.4,12p12.1,NM_004985.5(KRAS):c.173C>T (p.Thr58Ile),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894365,C,T,"missense_variant,coding_sequence_variant","T=0.000010 (1/101898, ExAC).T=0.00003 (3/89930, ALFA).T=0.00000 (0/78696, PAGE_STUDY)",7,https://www.ncbi.nlm.nih.gov/snp/rs104894365,Pathogenic,RCV000013420.24,12p12.1,NM_004985.5(KRAS):c.40G>A (p.Val14Ile),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs104894365,C,T,"missense_variant,coding_sequence_variant","T=0.000010 (1/101898, ExAC).T=0.00003 (3/89930, ALFA).T=0.00000 (0/78696, PAGE_STUDY)",7,https://www.ncbi.nlm.nih.gov/snp/rs104894365,Pathogenic,RCV000157945.7,12p12.1,NM_004985.5(KRAS):c.40G>A (p.Val14Ile),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894365,C,T,"missense_variant,coding_sequence_variant","T=0.000010 (1/101898, ExAC).T=0.00003 (3/89930, ALFA).T=0.00000 (0/78696, PAGE_STUDY)",7,https://www.ncbi.nlm.nih.gov/snp/rs104894365,Pathogenic,RCV000212499.18,12p12.1,NM_004985.5(KRAS):c.40G>A (p.Val14Ile),none provided,MedGen: CN517202
KRAS,rs104894365,C,T,"missense_variant,coding_sequence_variant","T=0.000010 (1/101898, ExAC).T=0.00003 (3/89930, ALFA).T=0.00000 (0/78696, PAGE_STUDY)",7,https://www.ncbi.nlm.nih.gov/snp/rs104894365,Pathogenic,RCV000521254.2,12p12.1,NM_004985.5(KRAS):c.40G>A (p.Val14Ile),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894365,C,T,"missense_variant,coding_sequence_variant","T=0.000010 (1/101898, ExAC).T=0.00003 (3/89930, ALFA).T=0.00000 (0/78696, PAGE_STUDY)",7,https://www.ncbi.nlm.nih.gov/snp/rs104894365,Pathogenic,RCV000844637.4,12p12.1,NM_004985.5(KRAS):c.40G>A (p.Val14Ile),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894365,C,T,"missense_variant,coding_sequence_variant","T=0.000010 (1/101898, ExAC).T=0.00003 (3/89930, ALFA).T=0.00000 (0/78696, PAGE_STUDY)",7,https://www.ncbi.nlm.nih.gov/snp/rs104894365,Pathogenic,RCV001266727.2,12p12.1,NM_004985.5(KRAS):c.40G>A (p.Val14Ile),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
KRAS,rs104894365,C,T,"missense_variant,coding_sequence_variant","T=0.000010 (1/101898, ExAC).T=0.00003 (3/89930, ALFA).T=0.00000 (0/78696, PAGE_STUDY)",7,https://www.ncbi.nlm.nih.gov/snp/rs104894365,Pathogenic,RCV001813184.2,12p12.1,NM_004985.5(KRAS):c.40G>A (p.Val14Ile),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
KRAS,rs104894366,G,A,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Pathogenic,RCV000150892.4,12p12.1,NM_004985.5(KRAS):c.101C>T (p.Pro34Leu),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894366,G,A,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Pathogenic,RCV000157668.2,12p12.1,NM_004985.5(KRAS):c.101C>T (p.Pro34Leu),none provided,MedGen: CN517202
KRAS,rs104894366,G,A,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Pathogenic,RCV000232330.4,12p12.1,NM_004985.5(KRAS):c.101C>T (p.Pro34Leu),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894366,G,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Pathogenic,RCV000043674.24,12p12.1,NM_004985.5(KRAS):c.101C>G (p.Pro34Arg),"Cardiofaciocutaneous syndrome 2 (CFC2)
                    ",MONDO: MONDO:0014112; MedGen: C3809005; Orphanet: 1340; OMIM: 615278
KRAS,rs104894366,G,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Pathogenic,RCV000207495.4,12p12.1,NM_004985.5(KRAS):c.101C>G (p.Pro34Arg),none provided,MedGen: CN517202
KRAS,rs104894366,G,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Likely-Pathogenic,RCV000211723.3,12p12.1,NM_004985.5(KRAS):c.101C>G (p.Pro34Arg),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs104894366,G,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Pathogenic,RCV000850569.1,12p12.1,NM_004985.5(KRAS):c.101C>G (p.Pro34Arg),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs104894366,G,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78694, PAGE_STUDY)",8,https://www.ncbi.nlm.nih.gov/snp/rs104894366,Pathogenic,RCV001851825.3,12p12.1,NM_004985.5(KRAS):c.101C>G (p.Pro34Arg),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs104894367,A,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant","G=0.000007 (1/140190, GnomAD).G=0.0002 (1/6404, 1000G_30x).C=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs104894367,Pathogenic,RCV000013422.23,12p12.1,NM_033360.4(KRAS):c.*9T>G,"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs112445441,C,A,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000038270.5,12p12.1,NM_004985.5(KRAS):c.38G>T (p.Gly13Val),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs112445441,C,A,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Likely-Pathogenic,RCV000422238.2,12p12.1,NM_004985.5(KRAS):c.38G>T (p.Gly13Val),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs112445441,C,A,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000439931.2,12p12.1,NM_004985.5(KRAS):c.38G>T (p.Gly13Val),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs112445441,C,G,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000431622.1,12p12.1,NM_033360.4(KRAS):c.38G>C (p.Gly13Ala),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs112445441,C,G,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000444986.1,12p12.1,NM_033360.4(KRAS):c.38G>C (p.Gly13Ala),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000013409.10,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),Breast adenocarcinoma,"Breast cancer, somatic; Breast adenocarcinoma, somatic"
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000038269.5,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000144967.8,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000144968.8,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),Autoimmune lymphoproliferative syndrome type 4,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; RAS-associated autoimmune leukoproliferative disorder"
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000421576.1,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000427102.1,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Likely-Pathogenic,RCV000431806.1,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000444192.1,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),Neoplasm of ovary,"Ovarian tumor; OVARIAN CANCER, SOMATIC; Ovarian neoplasm; See all synonyms [MedGen]"
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV000791297.3,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),"OCULOECTODERMAL SYNDROME, SOMATIC",
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV001092389.12,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),none provided,MedGen: CN517202
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV001266168.1,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV001526657.1,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),Nevus sebaceous,"NEVUS SEBACEOUS, SOMATIC"
KRAS,rs112445441,C,T,"missense_variant,coding_sequence_variant","T=0.000014 (2/140222, GnomAD).T=0.00000 (0/11862, ALFA)",40,https://www.ncbi.nlm.nih.gov/snp/rs112445441,Pathogenic,RCV001857340.1,12p12.1,NM_004985.5(KRAS):c.38G>A (p.Gly13Asp),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs121913236,G,C,"missense_variant,coding_sequence_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913236,Pathogenic,RCV000654936.4,12p12.1,NM_033360.4(KRAS):c.64C>G (p.Gln22Glu),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs121913236,G,T,"missense_variant,coding_sequence_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913236,Likely-Pathogenic,RCV000433522.1,12p12.1,NM_033360.4(KRAS):c.64C>A (p.Gln22Lys),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913236,G,T,"missense_variant,coding_sequence_variant,stop_gained",None,1,https://www.ncbi.nlm.nih.gov/snp/rs121913236,Likely-Pathogenic,RCV001078206.1,12p12.1,NM_033360.4(KRAS):c.64C>A (p.Gln22Lys),Linear nevus sebaceous syndrome,SFM syndrome; Jadassohn nevus phakomatosis; Nevus sebaceus of Jadassohn; See all synonyms [MedGen]
KRAS,rs121913238,G,C,"missense_variant,coding_sequence_variant,stop_gained",None,17,https://www.ncbi.nlm.nih.gov/snp/rs121913238,Likely-Pathogenic,RCV000422828.1,12p12.1,NM_033360.4(KRAS):c.181C>G (p.Gln61Glu),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913238,G,T,"missense_variant,coding_sequence_variant,stop_gained",None,17,https://www.ncbi.nlm.nih.gov/snp/rs121913238,Pathogenic,RCV000154402.5,12p12.1,NM_004985.5(KRAS):c.181C>A (p.Gln61Lys),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913238,G,T,"missense_variant,coding_sequence_variant,stop_gained",None,17,https://www.ncbi.nlm.nih.gov/snp/rs121913238,Pathogenic,RCV000423236.1,12p12.1,NM_004985.5(KRAS):c.181C>A (p.Gln61Lys),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913238,G,T,"missense_variant,coding_sequence_variant,stop_gained",None,17,https://www.ncbi.nlm.nih.gov/snp/rs121913238,Pathogenic,RCV000440889.1,12p12.1,NM_004985.5(KRAS):c.181C>A (p.Gln61Lys),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913240,T,A,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000038258.5,12p12.1,NM_004985.5(KRAS):c.182A>T (p.Gln61Leu),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913240,T,A,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Likely-Pathogenic,RCV000202407.1,12p12.1,NM_004985.5(KRAS):c.182A>T (p.Gln61Leu),"Medullary thyroid carcinoma (MTC)
                    ",Medullary thyroid gland carcinoma
KRAS,rs121913240,T,A,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000437806.1,12p12.1,NM_004985.5(KRAS):c.182A>T (p.Gln61Leu),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913240,T,A,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000443593.1,12p12.1,NM_004985.5(KRAS):c.182A>T (p.Gln61Leu),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913240,T,A,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Likely-Pathogenic,RCV000984128.1,12p12.1,NM_004985.5(KRAS):c.182A>T (p.Gln61Leu),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
KRAS,rs121913240,T,C,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000038257.4,12p12.1,NM_004985.5(KRAS):c.182A>G (p.Gln61Arg),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs121913240,T,C,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000420152.1,12p12.1,NM_004985.5(KRAS):c.182A>G (p.Gln61Arg),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913240,T,C,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000431260.1,12p12.1,NM_004985.5(KRAS):c.182A>G (p.Gln61Arg),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913240,T,C,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000438012.1,12p12.1,NM_004985.5(KRAS):c.182A>G (p.Gln61Arg),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913240,T,G,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Pathogenic,RCV000419507.1,12p12.1,NM_033360.4(KRAS):c.182A>C (p.Gln61Pro),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913240,T,G,"missense_variant,coding_sequence_variant",None,20,https://www.ncbi.nlm.nih.gov/snp/rs121913240,Likely-Pathogenic,RCV000429766.1,12p12.1,NM_033360.4(KRAS):c.182A>C (p.Gln61Pro),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913527,C,A,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Likely-Pathogenic,RCV000473918.6,12p12.1,NM_033360.4(KRAS):c.436G>T (p.Ala146Ser),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs121913527,C,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Pathogenic,RCV000444020.1,12p12.1,NM_033360.4(KRAS):c.436G>C (p.Ala146Pro),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913527,C,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Likely-Pathogenic,RCV000984134.1,12p12.1,NM_033360.4(KRAS):c.436G>C (p.Ala146Pro),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
KRAS,rs121913527,C,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Likely-Pathogenic,RCV001861474.3,12p12.1,NM_033360.4(KRAS):c.436G>C (p.Ala146Pro),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs121913527,C,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Pathogenic,RCV002259922.1,12p12.1,NM_033360.4(KRAS):c.436G>C (p.Ala146Pro),Autoimmune lymphoproliferative syndrome type 4,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; RAS-associated autoimmune leukoproliferative disorder"
KRAS,rs121913527,C,T,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Pathogenic,RCV000426420.1,12p12.1,NM_004985.5(KRAS):c.436G>A (p.Ala146Thr),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913527,C,T,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Pathogenic,RCV000791298.3,12p12.1,NM_004985.5(KRAS):c.436G>A (p.Ala146Thr),"OCULOECTODERMAL SYNDROME, SOMATIC",
KRAS,rs121913527,C,T,"missense_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/11862, ALFA).T=0.00000 (0/11862, ALFA)",10,https://www.ncbi.nlm.nih.gov/snp/rs121913527,Likely-Pathogenic,RCV001852208.3,12p12.1,NM_004985.5(KRAS):c.436G>A (p.Ala146Thr),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs121913528,C,A,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs121913528,Pathogenic-Likely-Pathogenic,RCV000207502.8,12p12.1,NM_033360.4(KRAS):c.175G>T (p.Ala59Ser),none provided,MedGen: CN517202
KRAS,rs121913528,C,T,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs121913528,Pathogenic,RCV000013410.4,12p12.1,NM_033360.4(KRAS):c.175G>A (p.Ala59Thr),"Bladder cancer, transitional cell, somatic",MedGen: C4016403
KRAS,rs121913528,C,T,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs121913528,Likely-Pathogenic,RCV000423066.1,12p12.1,NM_033360.4(KRAS):c.175G>A (p.Ala59Thr),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000013413.5,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),Carcinoma of pancreas,"PANCREATIC ACINAR CARCINOMA; PANCREATIC CARCINOMA; Pancreatic cancer, somatic; See all synonyms [MedGen]"
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000029216.5,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),Nevus sebaceous,"NEVUS SEBACEOUS, SOMATIC"
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000150895.3,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000154262.5,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000157944.9,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),none provided,MedGen: CN517202
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000417765.1,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000428010.1,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),Neoplasm of ovary,"Ovarian tumor; OVARIAN CANCER, SOMATIC; Ovarian neoplasm; See all synonyms [MedGen]"
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000439101.1,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Likely-Pathogenic,RCV000439750.1,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KRAS,rs121913529,C,A,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000585801.2,12p12.1,NM_004985.5(KRAS):c.35G>T (p.Gly12Val),"Cerebral arteriovenous malformation (BAVM)
                    ",CEREBRAL ARTERIOVENOUS MALFORMATIONS; Arteriovenous malformations of the brain
KRAS,rs121913529,C,G,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000038266.5,12p12.1,NM_004985.5(KRAS):c.35G>C (p.Gly12Ala),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913529,C,G,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000434342.1,12p12.1,NM_004985.5(KRAS):c.35G>C (p.Gly12Ala),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913529,C,G,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Likely-Pathogenic,RCV000441134.1,12p12.1,NM_004985.5(KRAS):c.35G>C (p.Gly12Ala),Gastrointestinal stromal tumor,"Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor"
KRAS,rs121913529,C,G,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000443636.1,12p12.1,NM_004985.5(KRAS):c.35G>C (p.Gly12Ala),Neoplasm of ovary,"Ovarian tumor; OVARIAN CANCER, SOMATIC; Ovarian neoplasm; See all synonyms [MedGen]"
KRAS,rs121913529,C,G,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000984117.1,12p12.1,NM_004985.5(KRAS):c.35G>C (p.Gly12Ala),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
KRAS,rs121913529,C,G,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV001374446.1,12p12.1,NM_004985.5(KRAS):c.35G>C (p.Gly12Ala),Gallbladder cancer,MONDO: MONDO:0005411; MedGen: C0153452
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000013411.10,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Carcinoma of pancreas,"PANCREATIC ACINAR CARCINOMA; PANCREATIC CARCINOMA; Pancreatic cancer, somatic; See all synonyms [MedGen]"
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000013412.9,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Neoplasm of stomach,Neoplasm of the stomach; Gastric neoplasm; Stomach Neoplasms
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000022799.9,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Epidermal nevus,"NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC; Nevus, epidermal, somatic"
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000029214.9,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Nevus sebaceous,"NEVUS SEBACEOUS, SOMATIC"
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000029215.11,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Linear nevus sebaceous syndrome,SFM syndrome; Jadassohn nevus phakomatosis; Nevus sebaceus of Jadassohn; See all synonyms [MedGen]
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000144969.11,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000144970.7,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Autoimmune lymphoproliferative syndrome type 4,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; RAS-associated autoimmune leukoproliferative disorder"
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000150896.6,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000150897.6,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Neoplasm of ovary,"Ovarian tumor; OVARIAN CANCER, SOMATIC; Ovarian neoplasm; See all synonyms [MedGen]"
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000272938.5,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),none provided,MedGen: CN517202
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Likely-Pathogenic,RCV000425250.2,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Lung carcinoma,MONDO: MONDO:0005138; MedGen: C0684249
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000426369.2,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic-Likely-Pathogenic,RCV000433573.3,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000443973.2,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000548006.2,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000585796.3,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),"Cerebral arteriovenous malformation (BAVM)
                    ",CEREBRAL ARTERIOVENOUS MALFORMATIONS; Arteriovenous malformations of the brain
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Likely-Pathogenic,RCV000662266.2,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Vascular Tumors Including Pyogenic Granuloma,
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV000856666.2,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),Primary low grade serous adenocarcinoma of ovary,MedGen: C4302356
KRAS,rs121913529,C,T,"missense_variant,coding_sequence_variant","T=0.000004 (1/249328, GnomAD_exome).T=0.000014 (2/140236, GnomAD).T=0.000010 (1/101828, ALFA)",50,https://www.ncbi.nlm.nih.gov/snp/rs121913529,Pathogenic,RCV001799604.2,12p12.1,NM_004985.5(KRAS):c.35G>A (p.Gly12Asp),"Capillary malformation-arteriovenous malformation 1 (CMAVM1)
                    ",MONDO: MONDO:0020783; MedGen: C4747394; Orphanet: 137667; OMIM: 608354
KRAS,rs121913530,C,A,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000013406.7,12p12.1,NM_004985.5(KRAS):c.34G>T (p.Gly12Cys),Lung carcinoma,MONDO: MONDO:0005138; MedGen: C0684249
KRAS,rs121913530,C,A,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000038265.5,12p12.1,NM_004985.5(KRAS):c.34G>T (p.Gly12Cys),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913530,C,A,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000418063.1,12p12.1,NM_004985.5(KRAS):c.34G>T (p.Gly12Cys),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913530,C,A,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000420450.1,12p12.1,NM_004985.5(KRAS):c.34G>T (p.Gly12Cys),Neoplasm of ovary,"Ovarian tumor; OVARIAN CANCER, SOMATIC; Ovarian neoplasm; See all synonyms [MedGen]"
KRAS,rs121913530,C,A,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Likely-Pathogenic,RCV000431049.1,12p12.1,NM_004985.5(KRAS):c.34G>T (p.Gly12Cys),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
KRAS,rs121913530,C,A,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000435281.1,12p12.1,NM_004985.5(KRAS):c.34G>T (p.Gly12Cys),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913530,C,A,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV001292543.1,12p12.1,NM_004985.5(KRAS):c.34G>T (p.Gly12Cys),Gallbladder cancer,MONDO: MONDO:0005411; MedGen: C0153452
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000013407.4,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),Squamous cell lung carcinoma,"Lung cancer, squamous cell, somatic; Squamous cell carcinoma of lung"
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000013408.4,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),Malignant tumor of urinary bladder,Urinary bladder cancer; Urinary Bladder Neoplasms; Bladder cancer
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000154401.5,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000422773.1,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000433472.1,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),Neoplasm of ovary,"Ovarian tumor; OVARIAN CANCER, SOMATIC; Ovarian neoplasm; See all synonyms [MedGen]"
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000441777.1,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000585776.1,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),Adenoid cystic carcinoma,Adenocystic carcinoma
KRAS,rs121913530,C,G,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV001356365.4,12p12.1,NM_004985.5(KRAS):c.34G>C (p.Gly12Arg),none provided,MedGen: CN517202
KRAS,rs121913530,C,T,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000013414.8,12p12.1,NM_004985.5(KRAS):c.34G>A (p.Gly12Ser),Gastric cancer,Stomach cancer; Malignant tumor of stomach
KRAS,rs121913530,C,T,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000038264.5,12p12.1,NM_004985.5(KRAS):c.34G>A (p.Gly12Ser),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913530,C,T,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000144971.6,12p12.1,NM_004985.5(KRAS):c.34G>A (p.Gly12Ser),"Juvenile myelomonocytic leukemia (JMML)
                    ","LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC"
KRAS,rs121913530,C,T,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000432392.1,12p12.1,NM_004985.5(KRAS):c.34G>A (p.Gly12Ser),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913530,C,T,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000445081.1,12p12.1,NM_004985.5(KRAS):c.34G>A (p.Gly12Ser),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913530,C,T,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV000782191.9,12p12.1,NM_004985.5(KRAS):c.34G>A (p.Gly12Ser),none provided,MedGen: CN517202
KRAS,rs121913530,C,T,"missense_variant,coding_sequence_variant","T=0.000008 (2/264690, TOPMED).T=0.000007 (1/140226, GnomAD).A=0.000020 (2/101218, ExAC)",31,https://www.ncbi.nlm.nih.gov/snp/rs121913530,Pathogenic,RCV001851824.1,12p12.1,NM_004985.5(KRAS):c.34G>A (p.Gly12Ser),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs121913535,C,A,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000038268.5,12p12.1,NM_004985.5(KRAS):c.37G>T (p.Gly13Cys),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913535,C,A,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000144972.4,12p12.1,NM_004985.5(KRAS):c.37G>T (p.Gly13Cys),Autoimmune lymphoproliferative syndrome type 4,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; RAS-associated autoimmune leukoproliferative disorder"
KRAS,rs121913535,C,A,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000443868.1,12p12.1,NM_004985.5(KRAS):c.37G>T (p.Gly13Cys),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913535,C,A,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000681039.3,12p12.1,NM_004985.5(KRAS):c.37G>T (p.Gly13Cys),none provided,MedGen: CN517202
KRAS,rs121913535,C,G,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000013424.5,12p12.1,NM_004985.5(KRAS):c.37G>C (p.Gly13Arg),Pilocytic astrocytoma,"Pilocytic astrocytoma, somatic"
KRAS,rs121913535,C,G,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000038267.5,12p12.1,NM_004985.5(KRAS):c.37G>C (p.Gly13Arg),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913535,C,G,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000426673.1,12p12.1,NM_004985.5(KRAS):c.37G>C (p.Gly13Arg),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913535,C,G,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000436657.1,12p12.1,NM_004985.5(KRAS):c.37G>C (p.Gly13Arg),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913535,C,T,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000418407.1,12p12.1,NM_033360.4(KRAS):c.37G>A (p.Gly13Ser),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs121913535,C,T,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000429548.1,12p12.1,NM_033360.4(KRAS):c.37G>A (p.Gly13Ser),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs121913535,C,T,"missense_variant,coding_sequence_variant",None,19,https://www.ncbi.nlm.nih.gov/snp/rs121913535,Pathogenic,RCV000436018.1,12p12.1,NM_033360.4(KRAS):c.37G>A (p.Gly13Ser),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs121913538,C,A,"missense_variant,synonymous_variant,coding_sequence_variant","G=0.000007 (1/140274, GnomAD).A=0.00003 (1/32048, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913538,Likely-Pathogenic,RCV000433336.1,12p12.1,NM_033360.4(KRAS):c.57G>T (p.Leu19Phe),Angiosarcoma,MONDO: MONDO:0016982; MeSH: D006394; MedGen: C0018923; Human Phenotype Ontology: HP:0200058
KRAS,rs121913538,C,G,"missense_variant,synonymous_variant,coding_sequence_variant","G=0.000007 (1/140274, GnomAD).A=0.00003 (1/32048, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913538,Pathogenic,RCV000201922.3,12p12.1,NM_004985.5(KRAS):c.57G>C (p.Leu19Phe),"OCULOECTODERMAL SYNDROME, SOMATIC",
KRAS,rs121913538,C,G,"missense_variant,synonymous_variant,coding_sequence_variant","G=0.000007 (1/140274, GnomAD).A=0.00003 (1/32048, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121913538,Likely-Pathogenic,RCV000441871.1,12p12.1,NM_004985.5(KRAS):c.57G>C (p.Leu19Phe),Angiosarcoma,MONDO: MONDO:0016982; MeSH: D006394; MedGen: C0018923; Human Phenotype Ontology: HP:0200058
KRAS,rs193929331,T,C,"coding_sequence_variant,missense_variant","C=0.000 (0/478, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs193929331,Pathogenic,RCV000013427.21,12p12.1,NM_004985.5(KRAS):c.13A>G (p.Lys5Glu),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs193929331,T,C,"coding_sequence_variant,missense_variant","C=0.000 (0/478, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs193929331,Pathogenic-Likely-Pathogenic,RCV000149836.6,12p12.1,NM_004985.5(KRAS):c.13A>G (p.Lys5Glu),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs193929331,T,C,"coding_sequence_variant,missense_variant","C=0.000 (0/478, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs193929331,Pathogenic,RCV000364781.3,12p12.1,NM_004985.5(KRAS):c.13A>G (p.Lys5Glu),none provided,MedGen: CN517202
KRAS,rs193929331,T,C,"coding_sequence_variant,missense_variant","C=0.000 (0/478, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs193929331,Likely-Pathogenic,RCV000605141.3,12p12.1,NM_004985.5(KRAS):c.13A>G (p.Lys5Glu),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs387907205,A,C,"missense_variant,coding_sequence_variant","G=0.000 (0/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs387907205,Likely-Pathogenic,RCV000221667.3,12p12.1,NM_004985.5(KRAS):c.211T>G (p.Tyr71Asp),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
KRAS,rs387907205,A,C,"missense_variant,coding_sequence_variant","G=0.000 (0/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs387907205,Likely-Pathogenic,RCV000596230.3,12p12.1,NM_004985.5(KRAS):c.211T>G (p.Tyr71Asp),none provided,MedGen: CN517202
KRAS,rs387907205,A,G,"missense_variant,coding_sequence_variant","G=0.000 (0/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs387907205,Pathogenic,RCV000024617.21,12p12.1,NM_033360.4(KRAS):c.211T>C (p.Tyr71His),"Cardiofaciocutaneous syndrome 2 (CFC2)
                    ",MONDO: MONDO:0014112; MedGen: C3809005; Orphanet: 1340; OMIM: 615278
KRAS,rs387907206,T,C,"missense_variant,coding_sequence_variant","C=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs387907206,Pathogenic,RCV000024618.21,12p12.1,NM_033360.4(KRAS):c.439A>G (p.Lys147Glu),"Cardiofaciocutaneous syndrome 2 (CFC2)
                    ",MONDO: MONDO:0014112; MedGen: C3809005; Orphanet: 1340; OMIM: 615278
KRAS,rs387907206,T,C,"missense_variant,coding_sequence_variant","C=0.000 (0/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs387907206,Pathogenic-Likely-Pathogenic,RCV000520244.2,12p12.1,NM_033360.4(KRAS):c.439A>G (p.Lys147Glu),none provided,MedGen: CN517202
KRAS,rs397517040,G,A,"synonymous_variant,coding_sequence_variant","A=0.000004 (1/249446, GnomAD_exome).A=0.000010 (1/101766, ExAC).A=0.001 (1/998, GoNL)",1,https://www.ncbi.nlm.nih.gov/snp/rs397517040,Likely-Pathogenic,RCV000038271.4,12p12.1,NM_004985.5(KRAS):c.39C>T (p.Gly13=),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs397517040,G,T,"synonymous_variant,coding_sequence_variant","A=0.000004 (1/249446, GnomAD_exome).A=0.000010 (1/101766, ExAC).A=0.001 (1/998, GoNL)",1,https://www.ncbi.nlm.nih.gov/snp/rs397517040,Likely-Pathogenic,RCV000150894.4,12p12.1,NM_004985.5(KRAS):c.39C>A (p.Gly13=),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs397517041,C,A,"missense_variant,coding_sequence_variant,3_prime_UTR_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs397517041,Likely-Pathogenic,RCV000038273.4,12p12.1,NM_004985.5(KRAS):c.454G>T (p.Val152Phe),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs397517042,A,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs397517042,Likely-Pathogenic,RCV000038275.5,12p12.1,NM_004985.5(KRAS):c.466T>G (p.Phe156Val),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs397517042,A,C,"missense_variant,coding_sequence_variant,3_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs397517042,Pathogenic,RCV000157941.1,12p12.1,NM_004985.5(KRAS):c.466T>G (p.Phe156Val),none provided,MedGen: CN517202
KRAS,rs397517042,A,T,"missense_variant,coding_sequence_variant,3_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs397517042,Pathogenic,RCV000150884.3,12p12.1,NM_004985.5(KRAS):c.466T>A (p.Phe156Ile),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs397517042,A,T,"missense_variant,coding_sequence_variant,3_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs397517042,Pathogenic,RCV000493013.1,12p12.1,NM_004985.5(KRAS):c.466T>A (p.Phe156Ile),none provided,MedGen: CN517202
KRAS,rs397517042,A,T,"missense_variant,coding_sequence_variant,3_prime_UTR_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs397517042,Pathogenic,RCV001813760.2,12p12.1,NM_004985.5(KRAS):c.466T>A (p.Phe156Ile),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs606231202,-,dupCCA,"inframe_insertion,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs606231202,Pathogenic,RCV000013415.25,12p12.1,NM_033360.4(KRAS):c.27_29dup (p.Gly10dup),"Acute myeloid leukemia (AML)
                    ","Acute myeloid leukemia, adult; AML adult; Acute myelogenous leukemia; See all synonyms [MedGen]"
KRAS,rs727503108,C,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251328, GnomAD_exome).A=0.00005 (1/21382, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs727503108,Likely-Pathogenic,RCV000150889.3,12p12.1,NM_004985.5(KRAS):c.179G>T (p.Gly60Val),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
KRAS,rs727503108,C,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251328, GnomAD_exome).A=0.00005 (1/21382, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs727503108,Likely-Pathogenic,RCV000157936.4,12p12.1,NM_004985.5(KRAS):c.179G>T (p.Gly60Val),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs727503108,C,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251328, GnomAD_exome).A=0.00005 (1/21382, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs727503108,Pathogenic-Likely-Pathogenic,RCV000212500.3,12p12.1,NM_004985.5(KRAS):c.179G>T (p.Gly60Val),none provided,MedGen: C3661900
KRAS,rs727503108,C,A,"missense_variant,coding_sequence_variant","A=0.000004 (1/251328, GnomAD_exome).A=0.00005 (1/21382, ALFA)",5,https://www.ncbi.nlm.nih.gov/snp/rs727503108,Pathogenic,RCV001850055.1,12p12.1,NM_004985.5(KRAS):c.179G>T (p.Gly60Val),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs727503109,T,C,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs727503109,Pathogenic-Likely-Pathogenic,RCV000150891.8,12p12.1,NM_004985.5(KRAS):c.108A>G (p.Ile36Met),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs727503109,T,C,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs727503109,Likely-Pathogenic,RCV000260877.6,12p12.1,NM_004985.5(KRAS):c.108A>G (p.Ile36Met),none provided,MedGen: CN517202
KRAS,rs727503109,T,C,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs727503109,Likely-Pathogenic,RCV000844636.3,12p12.1,NM_004985.5(KRAS):c.108A>G (p.Ile36Met),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs727503109,T,C,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs727503109,Pathogenic,RCV000856729.1,12p12.1,NM_004985.5(KRAS):c.108A>G (p.Ile36Met),"Cardiofaciocutaneous syndrome 1 (CFC1)
                    ",Congenital heart defects characteristic facial appearance ectodermal abnormalities and growth failure
KRAS,rs727503110,T,A,"missense_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs727503110,Pathogenic,RCV000157947.1,12p12.1,NM_033360.4(KRAS):c.65A>T (p.Gln22Leu),none provided,MedGen: CN517202
KRAS,rs727503110,T,C,"missense_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs727503110,Pathogenic,RCV000150893.5,12p12.1,NM_004985.5(KRAS):c.65A>G (p.Gln22Arg),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs727503110,T,C,"missense_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs727503110,Pathogenic,RCV000157667.2,12p12.1,NM_004985.5(KRAS):c.65A>G (p.Gln22Arg),none provided,MedGen: CN517202
KRAS,rs727503110,T,C,"missense_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs727503110,Pathogenic,RCV000157946.6,12p12.1,NM_004985.5(KRAS):c.65A>G (p.Gln22Arg),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs727503110,T,C,"missense_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs727503110,Pathogenic,RCV000506533.6,12p12.1,NM_004985.5(KRAS):c.65A>G (p.Gln22Arg),AllHighlyPenetrant,MedGen: CN169374
KRAS,rs727503110,T,C,"missense_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs727503110,Pathogenic,RCV000576784.1,12p12.1,NM_004985.5(KRAS):c.65A>G (p.Gln22Arg),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs727503110,T,C,"missense_variant,coding_sequence_variant",None,6,https://www.ncbi.nlm.nih.gov/snp/rs727503110,Pathogenic,RCV001095664.3,12p12.1,NM_004985.5(KRAS):c.65A>G (p.Gln22Arg),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
KRAS,rs727504662,T,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/11862, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs727504662,Pathogenic,RCV000155926.4,12p12.1,NM_004985.5(KRAS):c.214A>T (p.Met72Leu),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
KRAS,rs727504662,T,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/11862, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs727504662,Likely-Pathogenic,RCV001857536.3,12p12.1,NM_004985.5(KRAS):c.214A>T (p.Met72Leu),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs727504662,T,G,"missense_variant,coding_sequence_variant","A=0.00000 (0/11862, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs727504662,Likely-Pathogenic,RCV001315183.2,12p12.1,NM_004985.5(KRAS):c.214A>C (p.Met72Leu),RASopathy,rasopathies; Noonan spectrum disorder
KRAS,rs770248150,T,A,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Pathogenic,RCV000433195.1,12p12.1,NM_033360.4(KRAS):c.351A>T (p.Lys117Asn),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Pathogenic,RCV000425583.1,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Likely-Pathogenic,RCV000425803.1,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),Carcinoma of esophagus,Oesophageal carcinoma; Esophageal carcinoma
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Likely-Pathogenic,RCV000435219.1,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Likely-Pathogenic,RCV000435839.1,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),"Multiple myeloma (MM)
                    ",Plasma cell myeloma; Kahler disease; Myelomatosis; See all synonyms [MedGen]
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Likely-Pathogenic,RCV000442858.1,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),"Hepatocellular carcinoma (HCC)
                    ",Primary carcinoma of liver; Hepatoma; LIVER CELL CARCINOMA; See all synonyms [MedGen]
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Likely-Pathogenic,RCV000443670.1,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),Gastric adenocarcinoma,Adenocarcinoma of stomach
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Pathogenic,RCV001200581.7,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),none provided,MedGen: CN517202
KRAS,rs770248150,T,G,"coding_sequence_variant,missense_variant,synonymous_variant","G=0.000004 (1/251128, GnomAD_exome).G=0.000008 (1/121286, ExAC).A=0.00000 (0/10680, ALFA)",9,https://www.ncbi.nlm.nih.gov/snp/rs770248150,Pathogenic,RCV001731671.1,12p12.1,NM_033360.4(KRAS):c.351A>C (p.Lys117Asn),"Encephalocraniocutaneous lipomatosis (ECCL)
                    ",MONDO: MONDO:0013074; MedGen: C0406612; Orphanet: 2396; OMIM: 613001
KRAS,rs1057519725,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/139980, GnomAD).A=0.00000 (0/11862, ALFA)",12,https://www.ncbi.nlm.nih.gov/snp/rs1057519725,Pathogenic,RCV000434735.1,12p12.1,NM_004985.5(KRAS):c.437C>T (p.Ala146Val),Thyroid tumor,Neoplasm of the thyroid gland
KRAS,rs1057519725,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/139980, GnomAD).A=0.00000 (0/11862, ALFA)",12,https://www.ncbi.nlm.nih.gov/snp/rs1057519725,Pathogenic,RCV000441300.1,12p12.1,NM_004985.5(KRAS):c.437C>T (p.Ala146Val),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
KRAS,rs1057519725,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.000007 (1/139980, GnomAD).A=0.00000 (0/11862, ALFA)",12,https://www.ncbi.nlm.nih.gov/snp/rs1057519725,Pathogenic,RCV000791299.3,12p12.1,NM_004985.5(KRAS):c.437C>T (p.Ala146Val),"OCULOECTODERMAL SYNDROME, SOMATIC",
KRAS,rs1135401776,T,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1135401776,Pathogenic,RCV000496202.1,12p12.1,NM_033360.4(KRAS):c.440A>G (p.Lys147Arg),"Noonan syndrome 3 (NS3)
                    ",KRAS gene related Noonan syndrome
LZTR1,rs587777177,C,A,"stop_gained,missense_variant,coding_sequence_variant","T=0.000015 (4/264690, TOPMED).T=0.000016 (4/251186, GnomAD_exome).T=0.000007 (1/140272, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs587777177#publications,Pathogenic,RCV001384966.2,22q11.21,NM_006767.4(LZTR1):c.365C>A (p.Ser122Ter),none provided,MedGen: CN517202
LZTR1,rs587777177,C,T,"stop_gained,missense_variant,coding_sequence_variant","T=0.000015 (4/264690, TOPMED).T=0.000016 (4/251186, GnomAD_exome).T=0.000007 (1/140272, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs587777177#publications,Pathogenic,RCV000087293.4,22q11.21,NM_006767.4(LZTR1):c.365C>T (p.Ser122Leu),"Schwannomatosis 2 (SWNTS2)
                    ","Schwannomatosis-2, susceptibility to"
LZTR1,rs587777177,C,T,"stop_gained,missense_variant,coding_sequence_variant","T=0.000015 (4/264690, TOPMED).T=0.000016 (4/251186, GnomAD_exome).T=0.000007 (1/140272, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs587777177#publications,Pathogenic,RCV001200448.8,22q11.21,NM_006767.4(LZTR1):c.365C>T (p.Ser122Leu),none provided,MedGen: CN517202
LZTR1,rs587777178,C,T,"missense_variant,coding_sequence_variant","T=0.000045 (12/264690, TOPMED).T=0.000044 (11/248230, GnomAD_exome).T=0.000057 (8/140182, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs587777178,Likely-Pathogenic,RCV000087294.5,22q11.21,NM_006767.4(LZTR1):c.2062C>T (p.Arg688Cys),"Schwannomatosis 2 (SWNTS2)
                    ","Schwannomatosis-2, susceptibility to"
LZTR1,rs587777180,G,A,"missense_variant,coding_sequence_variant","A=0.000042 (11/264690, TOPMED).A=0.000032 (8/247306, GnomAD_exome).A=0.000057 (8/140290, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs587777180,Pathogenic,RCV000087296.4,22q11.21,NM_006767.4(LZTR1):c.1397G>A (p.Arg466Gln),"Schwannomatosis 2 (SWNTS2)
                    ","Schwannomatosis-2, susceptibility to"
LZTR1,rs587777180,G,A,"missense_variant,coding_sequence_variant","A=0.000042 (11/264690, TOPMED).A=0.000032 (8/247306, GnomAD_exome).A=0.000057 (8/140290, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs587777180,Likely-Pathogenic,RCV001260384.1,22q11.21,NM_006767.4(LZTR1):c.1397G>A (p.Arg466Gln),"Schwannomatosis (SWNTS1)
                    ",MONDO: MONDO:0008075; MeSH: C536641; MedGen: C1335929; OMIM: PS162091
LZTR1,rs587777180,G,A,"missense_variant,coding_sequence_variant","A=0.000042 (11/264690, TOPMED).A=0.000032 (8/247306, GnomAD_exome).A=0.000057 (8/140290, GnomAD)",1,https://www.ncbi.nlm.nih.gov/snp/rs587777180,Likely-Pathogenic,RCV001813376.1,22q11.21,NM_006767.4(LZTR1):c.1397G>A (p.Arg466Gln),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
LZTR1,rs797045165,C,T,"coding_sequence_variant,missense_variant","T=0.000004 (1/264690, TOPMED).T=0.000007 (1/140202, GnomAD).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs797045165,Pathogenic,RCV000191028.5,22q11.21,NM_006767.4(LZTR1):c.850C>T (p.Arg284Cys),"Noonan syndrome 10 (NS10)
                    ",MONDO: MONDO:0014693; MedGen: C4225280; Orphanet: 648; OMIM: 616564
LZTR1,rs797045165,C,T,"coding_sequence_variant,missense_variant","T=0.000004 (1/264690, TOPMED).T=0.000007 (1/140202, GnomAD).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs797045165,Pathogenic,RCV000658480.5,22q11.21,NM_006767.4(LZTR1):c.850C>T (p.Arg284Cys),none provided,MedGen: CN517202
LZTR1,rs797045165,C,T,"coding_sequence_variant,missense_variant","T=0.000004 (1/264690, TOPMED).T=0.000007 (1/140202, GnomAD).T=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs797045165,Pathogenic,RCV000763073.1,22q11.21,NM_006767.4(LZTR1):c.850C>T (p.Arg284Cys),"Schwannomatosis 2 (SWNTS2)
                    ","Schwannomatosis-2, susceptibility to"
LZTR1,rs797045166,G,A,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs797045166,Pathogenic,RCV000191029.3,22q11.21,NM_006767.4(LZTR1):c.740G>A (p.Ser247Asn),"Noonan syndrome 10 (NS10)
                    ",MONDO: MONDO:0014693; MedGen: C4225280; Orphanet: 648; OMIM: 616564
LZTR1,rs869320686,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.00006 (1/16760, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs869320686,Pathogenic,RCV000191027.7,22q11.21,NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg),"Noonan syndrome 10 (NS10)
                    ",MONDO: MONDO:0014693; MedGen: C4225280; Orphanet: 648; OMIM: 616564
LZTR1,rs869320686,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.00006 (1/16760, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs869320686,Pathogenic,RCV000413889.13,22q11.21,NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg),none provided,MedGen: CN517202
LZTR1,rs869320686,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.00006 (1/16760, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs869320686,Pathogenic,RCV000623699.3,22q11.21,NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
LZTR1,rs869320686,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.00006 (1/16760, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs869320686,Likely-Pathogenic,RCV000763072.2,22q11.21,NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg),"Schwannomatosis 2 (SWNTS2)
                    ","Schwannomatosis-2, susceptibility to"
LZTR1,rs869320686,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.00006 (1/16760, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs869320686,Pathogenic,RCV001175007.2,22q11.21,NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg),RASopathy,rasopathies; Noonan spectrum disorder
LZTR1,rs869320686,G,A,"coding_sequence_variant,missense_variant","A=0.000004 (1/264690, TOPMED).A=0.00006 (1/16760, 8.3KJPN).A=0.00000 (0/14050, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs869320686,Pathogenic,RCV001526613.2,22q11.21,NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg),"Fetal cystic hygroma (FCH)
                    ","Nuchal bleb, familial"
MAP2K1,rs121908594,T,C,"missense_variant,coding_sequence_variant","C=0.002 (1/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908594#publications,Pathogenic,RCV000014278.27,15q22.31,NM_002755.4(MAP2K1):c.158T>C (p.Phe53Ser),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs121908594,T,C,"missense_variant,coding_sequence_variant","C=0.002 (1/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908594#publications,Pathogenic,RCV000158002.2,15q22.31,NM_002755.4(MAP2K1):c.158T>C (p.Phe53Ser),none provided,MedGen: CN517202
MAP2K1,rs121908594,T,C,"missense_variant,coding_sequence_variant","C=0.002 (1/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121908594#publications,Pathogenic,RCV000520164.2,15q22.31,NM_002755.4(MAP2K1):c.158T>C (p.Phe53Ser),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs121908595,A,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/251460, GnomAD_exome)",10,https://www.ncbi.nlm.nih.gov/snp/rs121908595,Pathogenic,RCV000043672.41,15q22.31,NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs121908595,A,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/251460, GnomAD_exome)",10,https://www.ncbi.nlm.nih.gov/snp/rs121908595,Pathogenic,RCV000207506.16,15q22.31,NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys),none provided,MedGen: CN517202
MAP2K1,rs121908595,A,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/251460, GnomAD_exome)",10,https://www.ncbi.nlm.nih.gov/snp/rs121908595,Pathogenic,RCV000208757.6,15q22.31,NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs121908595,A,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/251460, GnomAD_exome)",10,https://www.ncbi.nlm.nih.gov/snp/rs121908595,Pathogenic,RCV000541525.7,15q22.31,NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs121908595,A,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/251460, GnomAD_exome)",10,https://www.ncbi.nlm.nih.gov/snp/rs121908595,Pathogenic,RCV000623321.2,15q22.31,NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
MAP2K1,rs121908595,A,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/251460, GnomAD_exome)",10,https://www.ncbi.nlm.nih.gov/snp/rs121908595,Pathogenic,RCV000763362.2,15q22.31,NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys),"Noonan syndrome 1 (NS1)
                    ","Turner Syndrome, Male; Turner phenotype with normal karyotype; Female pseudo-Turner syndrome"
MAP2K1,rs121908595,A,G,"missense_variant,coding_sequence_variant","G=0.000004 (1/251460, GnomAD_exome)",10,https://www.ncbi.nlm.nih.gov/snp/rs121908595,Pathogenic,RCV001197351.2,15q22.31,NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys),"Melorheostosis (MEL)
                    ","MELORHEOSTOSIS, ISOLATED"
MAP2K1,rs121908596,G,A,"missense_variant,coding_sequence_variant","T=0.000 (0/660, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121908596,Likely-Pathogenic,RCV000439613.1,15q22.31,NM_002755.4(MAP2K1):c.383G>A (p.Gly128Asp),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs121908596,G,C,"missense_variant,coding_sequence_variant","T=0.000 (0/660, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121908596,Pathogenic,RCV001724794.1,15q22.31,NM_002755.4(MAP2K1):c.383G>C (p.Gly128Ala),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs121908596,G,T,"missense_variant,coding_sequence_variant","T=0.000 (0/660, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121908596,Pathogenic,RCV000043673.20,15q22.31,NM_002755.4(MAP2K1):c.383G>T (p.Gly128Val),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs121908596,G,T,"missense_variant,coding_sequence_variant","T=0.000 (0/660, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121908596,Pathogenic-Likely-Pathogenic,RCV000207493.2,15q22.31,NM_002755.4(MAP2K1):c.383G>T (p.Gly128Val),none provided,MedGen: CN517202
MAP2K1,rs121908596,G,T,"missense_variant,coding_sequence_variant","T=0.000 (0/660, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121908596,Likely-Pathogenic,RCV000211725.3,15q22.31,NM_002755.4(MAP2K1):c.383G>T (p.Gly128Val),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs121908596,G,T,"missense_variant,coding_sequence_variant","T=0.000 (0/660, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs121908596,Pathogenic,RCV001234104.3,15q22.31,NM_002755.4(MAP2K1):c.383G>T (p.Gly128Val),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs397516789,C,T,"missense_variant,coding_sequence_variant","T=0.00003 (2/78696, PAGE_STUDY).T=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs397516789,Likely-Pathogenic,RCV000037590.5,15q22.31,NM_002755.4(MAP2K1):c.124C>T (p.Leu42Phe),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs397516789,C,T,"missense_variant,coding_sequence_variant","T=0.00003 (2/78696, PAGE_STUDY).T=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs397516789,Pathogenic,RCV001787832.1,15q22.31,NM_002755.4(MAP2K1):c.124C>T (p.Leu42Phe),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs397516790,A,C,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs397516790,Likely-Pathogenic,RCV000037591.7,15q22.31,NM_002755.4(MAP2K1):c.169A>C (p.Lys57Gln),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs397516790,A,C,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs397516790,Likely-Pathogenic,RCV000158014.8,15q22.31,NM_002755.4(MAP2K1):c.169A>C (p.Lys57Gln),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs397516790,A,G,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs397516790,Likely-Pathogenic,RCV000443354.2,15q22.31,NM_002755.4(MAP2K1):c.169A>G (p.Lys57Glu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs397516790,A,G,"missense_variant,coding_sequence_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs397516790,Pathogenic,RCV002051705.2,15q22.31,NM_002755.4(MAP2K1):c.169A>G (p.Lys57Glu),"Melorheostosis (MEL)
                    ","MELORHEOSTOSIS, ISOLATED"
MAP2K1,rs397516791,T,G,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs397516791,Likely-Pathogenic,RCV000158005.3,15q22.31,NM_002755.4(MAP2K1):c.275T>G (p.Leu92Arg),none provided,MedGen: C3661900
MAP2K1,rs397516791,T,G,"missense_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs397516791,Likely-Pathogenic,RCV000522848.4,15q22.31,NM_002755.4(MAP2K1):c.275T>G (p.Leu92Arg),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs397516792,C,A,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000418888.1,15q22.31,NM_002755.4(MAP2K1):c.371C>A (p.Pro124Gln),Malignant neoplasm of body of uterus,MedGen: C0153574
MAP2K1,rs397516792,C,A,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000419962.1,15q22.31,NM_002755.4(MAP2K1):c.371C>A (p.Pro124Gln),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs397516792,C,A,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000425396.1,15q22.31,NM_002755.4(MAP2K1):c.371C>A (p.Pro124Gln),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
MAP2K1,rs397516792,C,A,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000436127.1,15q22.31,NM_002755.4(MAP2K1):c.371C>A (p.Pro124Gln),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
MAP2K1,rs397516792,C,A,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Pathogenic,RCV001078439.1,15q22.31,NM_002755.4(MAP2K1):c.371C>A (p.Pro124Gln),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs397516792,C,G,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Pathogenic,RCV000413383.1,15q22.31,NM_002755.4(MAP2K1):c.371C>G (p.Pro124Arg),none provided,MedGen: CN517202
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Pathogenic-Likely-Pathogenic,RCV000037595.5,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000417448.1,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000424633.1,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000425638.1,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),Malignant neoplasm of body of uterus,MedGen: C0153574
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Likely-Pathogenic,RCV000435315.1,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Pathogenic,RCV000436322.1,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Pathogenic,RCV000680623.7,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),none provided,MedGen: CN517202
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Pathogenic,RCV001542689.2,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs397516792,C,T,"missense_variant,coding_sequence_variant",None,8,https://www.ncbi.nlm.nih.gov/snp/rs397516792,Pathogenic,RCV001813306.1,15q22.31,NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
MAP2K1,rs397516793,T,A,"missense_variant,coding_sequence_variant","C=0.00000 (0/78702, PAGE_STUDY).C=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs397516793,Pathogenic,RCV000787941.3,15q22.31,NM_002755.4(MAP2K1):c.388T>A (p.Tyr130Asn),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs397516793,T,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78702, PAGE_STUDY).C=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs397516793,Likely-Pathogenic,RCV000037596.6,15q22.31,NM_002755.4(MAP2K1):c.388T>C (p.Tyr130His),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs397516793,T,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78702, PAGE_STUDY).C=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs397516793,Pathogenic,RCV000623628.2,15q22.31,NM_002755.4(MAP2K1):c.388T>C (p.Tyr130His),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
MAP2K1,rs397516793,T,C,"missense_variant,coding_sequence_variant","C=0.00000 (0/78702, PAGE_STUDY).C=0.000 (0/660, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs397516793,Pathogenic,RCV001811234.3,15q22.31,NM_002755.4(MAP2K1):c.388T>C (p.Tyr130His),none provided,MedGen: CN517202
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV000158004.9,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV000192193.8,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV000208771.3,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV000212506.6,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),none provided,MedGen: CN517202
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Likely-Pathogenic,RCV000423708.2,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV000439184.2,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV000754677.2,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),Autism spectrum disorder,Autism spectrum disorders
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV000844673.4,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
MAP2K1,rs727504317,G,A,"missense_variant,coding_sequence_variant","A=0.00000 (0/10680, ALFA)",7,https://www.ncbi.nlm.nih.gov/snp/rs727504317,Pathogenic,RCV001095724.3,15q22.31,NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn),MAP2K1-related RASopathy,
MAP2K1,rs727504819,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000004 (1/251448, GnomAD_exome).A=0.000008 (1/121394, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs727504819,Likely-Pathogenic,RCV001027695.2,15q22.31,NM_002755.4(MAP2K1):c.323G>T (p.Arg108Leu),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs727504819,G,T,"missense_variant,coding_sequence_variant","A=0.000004 (1/264690, TOPMED).A=0.000004 (1/251448, GnomAD_exome).A=0.000008 (1/121394, ExAC)",1,https://www.ncbi.nlm.nih.gov/snp/rs727504819,Pathogenic,RCV001250384.1,15q22.31,NM_002755.4(MAP2K1):c.323G>T (p.Arg108Leu),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs730880502,T,A,"missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs730880502,Likely-Pathogenic,RCV000429680.1,15q22.31,NM_002755.4(MAP2K1):c.308T>A (p.Ile103Asn),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs797044593,A,G,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs797044593,Pathogenic,RCV000192194.2,15q22.31,NM_002755.4(MAP2K1):c.305A>G (p.Glu102Gly),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs797044593,A,G,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs797044593,Pathogenic,RCV001850428.2,15q22.31,NM_002755.4(MAP2K1):c.305A>G (p.Glu102Gly),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs869025339,AAG,delAAG,"coding_sequence_variant,inframe_deletion",None,2,https://www.ncbi.nlm.nih.gov/snp/rs869025339,Likely-Pathogenic,RCV000207500.1,15q22.31,NM_002755.4(MAP2K1):c.175_177del (p.Lys59del),none provided,MedGen: CN517202
MAP2K1,rs869025339,AAG,delAAG,"coding_sequence_variant,inframe_deletion",None,2,https://www.ncbi.nlm.nih.gov/snp/rs869025339,Pathogenic,RCV002277569.1,15q22.31,NM_002755.4(MAP2K1):c.175_177del (p.Lys59del),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs869025608,G,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000419591.1,15q22.31,NM_002755.4(MAP2K1):c.171G>C (p.Lys57Asn),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs869025608,G,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000420720.1,15q22.31,NM_002755.4(MAP2K1):c.171G>C (p.Lys57Asn),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
MAP2K1,rs869025608,G,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000427279.1,15q22.31,NM_002755.4(MAP2K1):c.171G>C (p.Lys57Asn),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
MAP2K1,rs869025608,G,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000429649.1,15q22.31,NM_002755.4(MAP2K1):c.171G>C (p.Lys57Asn),Gastric adenocarcinoma,Adenocarcinoma of stomach
MAP2K1,rs869025608,G,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000430292.1,15q22.31,NM_002755.4(MAP2K1):c.171G>C (p.Lys57Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs869025608,G,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000436816.1,15q22.31,NM_002755.4(MAP2K1):c.171G>C (p.Lys57Asn),Prostate adenocarcinoma,Adenocarcinoma of prostate
MAP2K1,rs869025608,G,C,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000437917.1,15q22.31,NM_002755.4(MAP2K1):c.171G>C (p.Lys57Asn),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K1,rs869025608,G,T,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Pathogenic,RCV000208748.2,15q22.31,NM_002755.4(MAP2K1):c.171G>T (p.Lys57Asn),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K1,rs869025608,G,T,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Pathogenic,RCV000421288.2,15q22.31,NM_002755.4(MAP2K1):c.171G>T (p.Lys57Asn),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
MAP2K1,rs869025608,G,T,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000428485.2,15q22.31,NM_002755.4(MAP2K1):c.171G>T (p.Lys57Asn),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K1,rs869025608,G,T,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Likely-Pathogenic,RCV000438528.2,15q22.31,NM_002755.4(MAP2K1):c.171G>T (p.Lys57Asn),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs869025608,G,T,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Pathogenic,RCV002051691.2,15q22.31,NM_002755.4(MAP2K1):c.171G>T (p.Lys57Asn),"Melorheostosis (MEL)
                    ","MELORHEOSTOSIS, ISOLATED"
MAP2K1,rs869025608,G,T,"synonymous_variant,coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs869025608,Pathogenic,RCV002254287.2,15q22.31,NM_002755.4(MAP2K1):c.171G>T (p.Lys57Asn),none provided,MedGen: CN517202
MAP2K1,rs876657651,A,G,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs876657651,Pathogenic,RCV000220187.6,15q22.31,NM_002755.4(MAP2K1):c.364A>G (p.Asn122Asp),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs876657651,A,G,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs876657651,Likely-Pathogenic,RCV000763361.1,15q22.31,NM_002755.4(MAP2K1):c.364A>G (p.Asn122Asp),"Noonan syndrome 1 (NS1)
                    ","Turner Syndrome, Male; Turner phenotype with normal karyotype; Female pseudo-Turner syndrome"
MAP2K1,rs876657651,A,G,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs876657651,Likely-Pathogenic,RCV000844674.3,15q22.31,NM_002755.4(MAP2K1):c.364A>G (p.Asn122Asp),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
MAP2K1,rs876657651,A,G,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs876657651,Pathogenic,RCV001312196.1,15q22.31,NM_002755.4(MAP2K1):c.364A>G (p.Asn122Asp),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs1057519728,T,A,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000421374.1,15q22.31,NM_002755.4(MAP2K1):c.157T>A (p.Phe53Ile),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
MAP2K1,rs1057519728,T,A,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000431446.1,15q22.31,NM_002755.4(MAP2K1):c.157T>A (p.Phe53Ile),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K1,rs1057519728,T,A,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000432046.1,15q22.31,NM_002755.4(MAP2K1):c.157T>A (p.Phe53Ile),Gastric adenocarcinoma,Adenocarcinoma of stomach
MAP2K1,rs1057519728,T,A,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000442281.1,15q22.31,NM_002755.4(MAP2K1):c.157T>A (p.Phe53Ile),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs1057519728,T,C,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Pathogenic,RCV000435966.1,15q22.31,NM_002755.4(MAP2K1):c.157T>C (p.Phe53Leu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519728,T,G,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000421852.1,15q22.31,NM_002755.4(MAP2K1):c.157T>G (p.Phe53Val),Gastric adenocarcinoma,Adenocarcinoma of stomach
MAP2K1,rs1057519728,T,G,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000422476.1,15q22.31,NM_002755.4(MAP2K1):c.157T>G (p.Phe53Val),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
MAP2K1,rs1057519728,T,G,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000429056.1,15q22.31,NM_002755.4(MAP2K1):c.157T>G (p.Phe53Val),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K1,rs1057519728,T,G,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519728,Likely-Pathogenic,RCV000439716.1,15q22.31,NM_002755.4(MAP2K1):c.157T>G (p.Phe53Val),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs1057519729,A,C,"coding_sequence_variant,missense_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs1057519729,Pathogenic,RCV000418731.2,15q22.31,NM_002755.4(MAP2K1):c.167A>C (p.Gln56Pro),"Non-small cell lung carcinoma (NSCLC)
                    ",Non-small cell lung cancer
MAP2K1,rs1057519729,A,C,"coding_sequence_variant,missense_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs1057519729,Likely-Pathogenic,RCV000429601.2,15q22.31,NM_002755.4(MAP2K1):c.167A>C (p.Gln56Pro),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519729,A,C,"coding_sequence_variant,missense_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs1057519729,Pathogenic,RCV002051704.2,15q22.31,NM_002755.4(MAP2K1):c.167A>C (p.Gln56Pro),"Melorheostosis (MEL)
                    ","MELORHEOSTOSIS, ISOLATED"
MAP2K1,rs1057519729,A,C,"coding_sequence_variant,missense_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs1057519729,Pathogenic,RCV002254296.2,15q22.31,NM_002755.4(MAP2K1):c.167A>C (p.Gln56Pro),none provided,MedGen: CN517202
MAP2K1,rs1057519730,T,A,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519730,Likely-Pathogenic,RCV000440339.1,15q22.31,NM_002755.4(MAP2K1):c.332T>A (p.Ile111Asn),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs1057519730,T,A,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519730,Pathogenic,RCV001237931.5,15q22.31,NM_002755.4(MAP2K1):c.332T>A (p.Ile111Asn),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs1057519730,T,G,"coding_sequence_variant,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519730,Pathogenic,RCV000434378.1,15q22.31,NM_002755.4(MAP2K1):c.332T>G (p.Ile111Ser),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519731,G,C,"coding_sequence_variant,missense_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs1057519731,Likely-Pathogenic,RCV000424259.1,15q22.31,NM_002755.4(MAP2K1):c.362G>C (p.Cys121Ser),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K1,rs1057519731,G,C,"coding_sequence_variant,missense_variant",None,5,https://www.ncbi.nlm.nih.gov/snp/rs1057519731,Pathogenic,RCV000441586.1,15q22.31,NM_002755.4(MAP2K1):c.362G>C (p.Cys121Ser),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519732,C,G,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Likely-Pathogenic,RCV002267695.1,15q22.31,NM_002755.4(MAP2K1):c.370C>G (p.Pro124Ala),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Likely-Pathogenic,RCV000426713.1,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),Transitional cell carcinoma of the bladder,MONDO: MONDO:0005611; MedGen: C0279680; Human Phenotype Ontology: HP:0006740
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Pathogenic,RCV000433235.1,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Likely-Pathogenic,RCV000433927.1,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),Malignant neoplasm of body of uterus,MedGen: C0153574
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Likely-Pathogenic,RCV000443916.1,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Likely-Pathogenic,RCV000444865.1,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Pathogenic,RCV000482718.2,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),none provided,MedGen: C3661900
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Likely-Pathogenic,RCV000989347.1,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs1057519732,C,T,"coding_sequence_variant,missense_variant",None,4,https://www.ncbi.nlm.nih.gov/snp/rs1057519732,Pathogenic,RCV001250385.1,15q22.31,NM_002755.4(MAP2K1):c.370C>T (p.Pro124Ser),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K1,rs1057519733,G,A,"coding_sequence_variant,stop_gained,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519733,Pathogenic,RCV000418114.1,15q22.31,NM_002755.4(MAP2K1):c.607G>A (p.Glu203Lys),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519733,G,A,"coding_sequence_variant,stop_gained,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519733,Likely-Pathogenic,RCV001266169.1,15q22.31,NM_002755.4(MAP2K1):c.607G>A (p.Glu203Lys),Inborn genetic diseases,MeSH: D030342; MedGen: C0950123
MAP2K1,rs1057519733,G,C,"coding_sequence_variant,stop_gained,missense_variant",None,3,https://www.ncbi.nlm.nih.gov/snp/rs1057519733,Pathogenic,RCV001795582.2,15q22.31,NM_002755.4(MAP2K1):c.607G>C (p.Glu203Gln),"Cardiofaciocutaneous syndrome 3 (CFC3)
                    ",MONDO: MONDO:0014113; MedGen: C3809006; Orphanet: 1340; OMIM: 615279
MAP2K1,rs1057519734,C,T,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519734,Pathogenic,RCV000430494.1,15q22.31,NM_002755.4(MAP2K1):c.790C>T (p.Pro264Ser),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519735,A,C,"genic_downstream_transcript_variant,3_prime_UTR_variant,coding_sequence_variant,missense_variant,non_coding_transcript_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519735,Pathogenic,RCV000441191.3,15q22.31,NM_002755.4(MAP2K1):c.1144A>C (p.Asn382His),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519805,T,C,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519805,Likely-Pathogenic,RCV000422377.1,15q22.31,NM_002755.4(MAP2K1):c.385T>C (p.Phe129Leu),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K1,rs1057519819,T,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519819,Likely-Pathogenic,RCV000420695.1,15q22.31,NM_002755.4(MAP2K1):c.296T>C (p.Ile99Thr),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs1057519820,A,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519820,Likely-Pathogenic,RCV000423068.1,15q22.31,NM_002755.4(MAP2K1):c.356A>C (p.His119Pro),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs1057519821,G,C,"coding_sequence_variant,missense_variant,synonymous_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519821,Likely-Pathogenic,RCV000433785.1,15q22.31,NM_002755.4(MAP2K1):c.360G>C (p.Glu120Asp),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs1057519821,G,T,"coding_sequence_variant,missense_variant,synonymous_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519821,Likely-Pathogenic,RCV000439225.1,15q22.31,NM_002755.4(MAP2K1):c.360G>T (p.Glu120Asp),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs1057519822,T,A,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519822,Likely-Pathogenic,RCV000422017.1,15q22.31,NM_002755.4(MAP2K1):c.632T>A (p.Val211Asp),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs1057519823,T,C,"coding_sequence_variant,missense_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs1057519823,Likely-Pathogenic,RCV000432883.1,15q22.31,NM_002755.4(MAP2K1):c.644T>C (p.Leu215Pro),Neoplasm,Neoplasms; Neoplasm (disease)
MAP2K1,rs1057519856,T,A,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519856,Likely-Pathogenic,RCV000439789.1,15q22.31,NM_002755.4(MAP2K1):c.361T>A (p.Cys121Ser),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K1,rs1057519908,T,G,"coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519908,Likely-Pathogenic,RCV000419468.1,15q22.31,NM_002755.4(MAP2K1):c.159T>G (p.Phe53Leu),Neoplasm of the large intestine,Colorectal Neoplasms; Colorectal neoplasm
MAP2K1,rs1057519908,T,G,"coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519908,Likely-Pathogenic,RCV000430169.1,15q22.31,NM_002755.4(MAP2K1):c.159T>G (p.Phe53Leu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs1057519908,T,G,"coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519908,Likely-Pathogenic,RCV000436917.1,15q22.31,NM_002755.4(MAP2K1):c.159T>G (p.Phe53Leu),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K1,rs1057519908,T,G,"coding_sequence_variant,synonymous_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519908,Likely-Pathogenic,RCV000440832.1,15q22.31,NM_002755.4(MAP2K1):c.159T>G (p.Phe53Leu),Gastric adenocarcinoma,Adenocarcinoma of stomach
MAP2K1,rs1057519909,A,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519909,Likely-Pathogenic,RCV000426154.1,15q22.31,NM_002755.4(MAP2K1):c.170A>C (p.Lys57Thr),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
MAP2K1,rs1057519909,A,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519909,Likely-Pathogenic,RCV000427226.1,15q22.31,NM_002755.4(MAP2K1):c.170A>C (p.Lys57Thr),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K1,rs1057519909,A,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519909,Likely-Pathogenic,RCV000436846.1,15q22.31,NM_002755.4(MAP2K1):c.170A>C (p.Lys57Thr),"Non-Hodgkin lymphoma (NHL)
                    ","Malignant lymphoma, non-Hodgkin; LYMPHOMA, NON-HODGKIN, SOMATIC"
MAP2K1,rs1057519909,A,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519909,Likely-Pathogenic,RCV000437934.1,15q22.31,NM_002755.4(MAP2K1):c.170A>C (p.Lys57Thr),Gastric adenocarcinoma,Adenocarcinoma of stomach
MAP2K1,rs1057519909,A,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519909,Likely-Pathogenic,RCV000442142.1,15q22.31,NM_002755.4(MAP2K1):c.170A>C (p.Lys57Thr),Prostate adenocarcinoma,Adenocarcinoma of prostate
MAP2K1,rs1057519909,A,C,"coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519909,Likely-Pathogenic,RCV000444739.1,15q22.31,NM_002755.4(MAP2K1):c.170A>C (p.Lys57Thr),Lung adenocarcinoma,"Adenocarcinoma of lung; Adenocarcinoma of lung, somatic"
MAP2K2,rs121434497,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.004 (2/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121434497#publications,Pathogenic,RCV000008761.4,19p13.3,NM_030662.4(MAP2K2):c.170T>G (p.Phe57Cys),"Cardiofaciocutaneous syndrome 4 (CFC4)
                    ",MONDO: MONDO:0014114; MedGen: C3809007; Orphanet: 1340; OMIM: 615280
MAP2K2,rs121434497,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.004 (2/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121434497#publications,Pathogenic,RCV000158038.3,19p13.3,NM_030662.4(MAP2K2):c.170T>G (p.Phe57Cys),none provided,MedGen: CN517202
MAP2K2,rs121434497,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.004 (2/478, ALFA)",2,https://www.ncbi.nlm.nih.gov/snp/rs121434497#publications,Pathogenic,RCV000208756.4,19p13.3,NM_030662.4(MAP2K2):c.170T>G (p.Phe57Cys),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K2,rs121434498,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.039 (31/786, PRJEB37584)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434498,Pathogenic,RCV000008762.4,19p13.3,NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val),"Cardiofaciocutaneous syndrome 4 (CFC4)
                    ",MONDO: MONDO:0014114; MedGen: C3809007; Orphanet: 1340; OMIM: 615280
MAP2K2,rs121434498,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.039 (31/786, PRJEB37584)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434498,Likely-Pathogenic,RCV000423711.1,19p13.3,NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
MAP2K2,rs121434498,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.039 (31/786, PRJEB37584)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434498,Likely-Pathogenic,RCV000434377.1,19p13.3,NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val),Gastric adenocarcinoma,Adenocarcinoma of stomach
MAP2K2,rs121434498,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.039 (31/786, PRJEB37584)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434498,Likely-Pathogenic,RCV000439181.1,19p13.3,NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K2,rs121434498,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.039 (31/786, PRJEB37584)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434498,Likely-Pathogenic,RCV000441583.1,19p13.3,NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
MAP2K2,rs121434498,A,C,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.039 (31/786, PRJEB37584)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434498,Pathogenic,RCV000521375.1,19p13.3,NM_030662.4(MAP2K2):c.169T>G (p.Phe57Val),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K2,rs121434498,A,G,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant","C=0.039 (31/786, PRJEB37584)",4,https://www.ncbi.nlm.nih.gov/snp/rs121434498,Pathogenic,RCV000158037.2,19p13.3,NM_030662.4(MAP2K2):c.169T>C (p.Phe57Leu),none provided,MedGen: C3661900
MAP2K2,rs121434499,A,G,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121434499,Likely-Pathogenic,RCV000008763.6,19p13.3,NM_030662.4(MAP2K2):c.400T>C (p.Tyr134His),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K2,rs121434499,A,G,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121434499,Pathogenic,RCV000043675.3,19p13.3,NM_030662.4(MAP2K2):c.400T>C (p.Tyr134His),"Cardiofaciocutaneous syndrome 4 (CFC4)
                    ",MONDO: MONDO:0014114; MedGen: C3809007; Orphanet: 1340; OMIM: 615280
MAP2K2,rs121434499,A,G,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121434499,Pathogenic-Likely-Pathogenic,RCV000158022.4,19p13.3,NM_030662.4(MAP2K2):c.400T>C (p.Tyr134His),none provided,MedGen: C3661900
MAP2K2,rs121434499,A,G,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121434499,Likely-Pathogenic,RCV000521479.2,19p13.3,NM_030662.4(MAP2K2):c.400T>C (p.Tyr134His),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs121434499,A,G,"genic_upstream_transcript_variant,missense_variant,coding_sequence_variant",None,2,https://www.ncbi.nlm.nih.gov/snp/rs121434499,Likely-Pathogenic,RCV001813182.1,19p13.3,NM_030662.4(MAP2K2):c.400T>C (p.Tyr134His),Noonan syndrome and Noonan-related syndrome,MONDO: MONDO:0020297; MedGen: CN260604; Orphanet: 98733
MAP2K2,rs267607230,G,A,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000008 (1/120888, ExAC).T=0.054 (26/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267607230,Pathogenic,RCV000824698.1,19p13.3,NM_030662.4(MAP2K2):c.383C>T (p.Pro128Leu),Castleman-Kojima disease,Thrombocytopenia-anasarca-fever-renal insufficiency-organomegaly syndrome; TAFRO syndrome
MAP2K2,rs267607230,G,T,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000008 (1/120888, ExAC).T=0.054 (26/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267607230,Pathogenic,RCV000008764.6,19p13.3,NM_030662.4(MAP2K2):c.383C>A (p.Pro128Gln),"Cardiofaciocutaneous syndrome 4 (CFC4)
                    ",MONDO: MONDO:0014114; MedGen: C3809007; Orphanet: 1340; OMIM: 615280
MAP2K2,rs267607230,G,T,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000008 (1/120888, ExAC).T=0.054 (26/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267607230,Pathogenic,RCV000158021.2,19p13.3,NM_030662.4(MAP2K2):c.383C>A (p.Pro128Gln),none provided,MedGen: CN517202
MAP2K2,rs267607230,G,T,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000008 (1/120888, ExAC).T=0.054 (26/478, ALFA)",3,https://www.ncbi.nlm.nih.gov/snp/rs267607230,Pathogenic,RCV000208770.3,19p13.3,NM_030662.4(MAP2K2):c.383C>A (p.Pro128Gln),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K2,rs387906800,C,A,"coding_sequence_variant,missense_variant,genic_upstream_transcript_variant","T=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387906800,Likely-Pathogenic,RCV002028395.3,19p13.3,NM_030662.4(MAP2K2):c.395G>T (p.Gly132Val),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs387906800,C,T,"coding_sequence_variant,missense_variant,genic_upstream_transcript_variant","T=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387906800,Likely-Pathogenic,RCV000023088.6,19p13.3,NM_030662.4(MAP2K2):c.395G>A (p.Gly132Asp),"Cardiofaciocutaneous syndrome 4 (CFC4)
                    ",MONDO: MONDO:0014114; MedGen: C3809007; Orphanet: 1340; OMIM: 615280
MAP2K2,rs387906800,C,T,"coding_sequence_variant,missense_variant,genic_upstream_transcript_variant","T=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387906800,Pathogenic,RCV000149835.1,19p13.3,NM_030662.4(MAP2K2):c.395G>A (p.Gly132Asp),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs387906800,C,T,"coding_sequence_variant,missense_variant,genic_upstream_transcript_variant","T=0.000 (0/478, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs387906800,Likely-Pathogenic,RCV000413893.1,19p13.3,NM_030662.4(MAP2K2):c.395G>A (p.Gly132Asp),none provided,MedGen: CN517202
MAP2K2,rs727504370,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant","C=0.00000 (0/10680, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs727504370,Pathogenic,RCV000154507.3,19p13.3,NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs727504370,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant","C=0.00000 (0/10680, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs727504370,Pathogenic,RCV000208747.3,19p13.3,NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K2,rs727504370,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant","C=0.00000 (0/10680, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs727504370,Pathogenic,RCV000412815.2,19p13.3,NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys),none provided,MedGen: CN517202
MAP2K2,rs727504370,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant","C=0.00000 (0/10680, ALFA)",4,https://www.ncbi.nlm.nih.gov/snp/rs727504370,Likely-Pathogenic,RCV000844676.4,19p13.3,NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
MAP2K2,rs727504382,C,T,"stop_gained,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs727504382,Pathogenic,RCV000158024.5,19p13.3,NM_030662.4(MAP2K2):c.619G>A (p.Glu207Lys),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs727504382,C,T,"stop_gained,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs727504382,Pathogenic-Likely-Pathogenic,RCV000254662.9,19p13.3,NM_030662.4(MAP2K2):c.619G>A (p.Glu207Lys),none provided,MedGen: CN517202
MAP2K2,rs727504382,C,T,"stop_gained,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs727504382,Likely-Pathogenic,RCV000524055.2,19p13.3,NM_030662.4(MAP2K2):c.619G>A (p.Glu207Lys),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K2,rs727504382,C,T,"stop_gained,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs727504382,Likely-Pathogenic,RCV000844675.3,19p13.3,NM_030662.4(MAP2K2):c.619G>A (p.Glu207Lys),"Noonan syndrome (NS)
                    ",Noonan's syndrome; Pseudo-Turner syndrome
MAP2K2,rs730880517,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs730880517,Pathogenic-Likely-Pathogenic,RCV000158039.3,19p13.3,NM_030662.4(MAP2K2):c.181A>G (p.Lys61Glu),none provided,MedGen: CN517202
MAP2K2,rs730880517,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs730880517,Likely-Pathogenic,RCV000200295.1,19p13.3,NM_030662.4(MAP2K2):c.181A>G (p.Lys61Glu),"Cardiofaciocutaneous syndrome 1 (CFC1)
                    ",Congenital heart defects characteristic facial appearance ectodermal abnormalities and growth failure
MAP2K2,rs730880517,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs730880517,Pathogenic,RCV001205317.5,19p13.3,NM_030662.4(MAP2K2):c.181A>G (p.Lys61Glu),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs730880517,T,C,"genic_upstream_transcript_variant,coding_sequence_variant,missense_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs730880517,Pathogenic,RCV001781338.2,19p13.3,NM_030662.4(MAP2K2):c.181A>G (p.Lys61Glu),"Cardiofaciocutaneous syndrome 4 (CFC4)
                    ",MONDO: MONDO:0014114; MedGen: C3809007; Orphanet: 1340; OMIM: 615280
MAP2K2,rs1057519806,T,C,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519806,Likely-Pathogenic,RCV000429584.1,19p13.3,NM_030662.4(MAP2K2):c.376A>G (p.Asn126Asp),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K2,rs1057519806,T,C,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519806,Likely-Pathogenic,RCV000824947.1,19p13.3,NM_030662.4(MAP2K2):c.376A>G (p.Asn126Asp),Cardio-facio-cutaneous syndrome,Cardiofaciocutaneous syndrome; CFC syndrome
MAP2K2,rs1057519806,T,C,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519806,Pathogenic,RCV000995803.2,19p13.3,NM_030662.4(MAP2K2):c.376A>G (p.Asn126Asp),"Cardiofaciocutaneous syndrome 4 (CFC4)
                    ",MONDO: MONDO:0014114; MedGen: C3809007; Orphanet: 1340; OMIM: 615280
MAP2K2,rs1057519806,T,C,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","G=0.000004 (1/264690, TOPMED).G=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519806,Likely-Pathogenic,RCV001851015.1,19p13.3,NM_030662.4(MAP2K2):c.376A>G (p.Asn126Asp),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs1057519807,A,T,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519807,Likely-Pathogenic,RCV000438500.1,19p13.3,NM_030662.4(MAP2K2):c.373T>A (p.Cys125Ser),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K2,rs1057519808,T,G,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519808,Likely-Pathogenic,RCV000421323.1,19p13.3,NM_030662.4(MAP2K2):c.179A>C (p.Gln60Pro),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K2,rs1057519809,G,A,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","C=0.000004 (1/264690, TOPMED).C=0.000004 (1/251424, GnomAD_exome).C=0.00000 (0/10680, ALFA)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519809,Likely-Pathogenic,RCV000432005.1,19p13.3,NM_030662.4(MAP2K2):c.136C>T (p.Leu46Phe),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K2,rs1057519810,C,T,"missense_variant,genic_upstream_transcript_variant,coding_sequence_variant","A=0.000004 (1/251194, GnomAD_exome)",1,https://www.ncbi.nlm.nih.gov/snp/rs1057519810,Likely-Pathogenic,RCV000444084.1,19p13.3,NM_030662.4(MAP2K2):c.103G>A (p.Val35Met),Melanoma,MONDO: MONDO:0005105; MeSH: D008545; MedGen: C0025202; Human Phenotype Ontology: HP:0002861
MAP2K2,rs1057519910,A,C,"missense_variant,synonymous_variant,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519910,Likely-Pathogenic,RCV000417753.1,19p13.3,NM_030662.4(MAP2K2):c.171T>G (p.Phe57Leu),"Malignant melanoma of skin (CMM)
                    ","Malignant melanoma, somatic; Cutaneous melanoma"
MAP2K2,rs1057519910,A,C,"missense_variant,synonymous_variant,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519910,Likely-Pathogenic,RCV000428429.1,19p13.3,NM_030662.4(MAP2K2):c.171T>G (p.Phe57Leu),Pancreatic adenocarcinoma,MONDO: MONDO:0006047; MedGen: C0281361; Human Phenotype Ontology: HP:0006725
MAP2K2,rs1057519910,A,C,"missense_variant,synonymous_variant,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519910,Likely-Pathogenic,RCV000429600.1,19p13.3,NM_030662.4(MAP2K2):c.171T>G (p.Phe57Leu),"Squamous cell carcinoma of the head and neck (HNSCC)
                    ","Head and neck squamous cell carcinoma; Carcinoma, squamous cell of head and neck; Squamous cell carcinoma, head and neck, somatic"
MAP2K2,rs1057519910,A,C,"missense_variant,synonymous_variant,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519910,Likely-Pathogenic,RCV000438529.1,19p13.3,NM_030662.4(MAP2K2):c.171T>G (p.Phe57Leu),Gastric adenocarcinoma,Adenocarcinoma of stomach
MAP2K2,rs1057519910,A,T,"missense_variant,synonymous_variant,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1057519910,Pathogenic,RCV000702132.5,19p13.3,NM_030662.4(MAP2K2):c.171T>A (p.Phe57Leu),RASopathy,rasopathies; Noonan spectrum disorder
MAP2K2,rs1114167351,ATC,delATC,"inframe_deletion,genic_upstream_transcript_variant,coding_sequence_variant",None,1,https://www.ncbi.nlm.nih.gov/snp/rs1114167351,Pathogenic,RCV000490823.1,19p13.3,NM_030662.4(MAP2K2):c.210_212del (p.Asp71del),Smith-Magenis Syndrome-like,MedGen: CN238491
